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ABSTRACT 
Cytokines are small-molecule signaling proteins involved in cell-cell regulation. 
The detection of low-abundance cytokines is challenging since the currently available 
techniques are limited by sensitivity and are time-consuming. Nanopore sensing is an 
emerging technique in nanotechnology that is catalyzing key breakthroughs in many 
areas, including the analysis and study of proteins at the single-molecule level. Solid-state 
nanopore sensing has the advantage of analyzing small copy numbers of biomolecules, 
such as DNA, with high throughput. However, protein detection using nanopores is still 
in in infancy because the mechanisms of native protein translocation inside the solid-state 
nanopore are highly complicated. The goal of this project is to develop a novel solid-state 
nanopore device for identification and quantification of cancer cytokines directly from 
cell culture. Vascular endothelial growth factor (VEGF) is chosen as a model cytokine 




Firstly, we used a nanopore sensor to monitor individual VEGF proteins in 
solution while simultaneously obtaining tertiary and quaternary structural information. 
Next, we used the translocation signature to identify VEGF secreted directly from the 
culture media of the breast cancer cell line. A series of DNA and RNA aptamers was 
screened to selectively bind to secreted VEGF, enhancing the detection rate and creating 
a unique translocation signature for easy protein discrimination. Finally, we integrated 
the nanopore with a hard microfluidic device designed to facilitate the on-chip sample 
preparation prior to nanopore sensing. This nanopore-microfluidic device may allow 
scientists and clinicians to directly detect biomarkers secreted from a small population of 
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CHAPTER 1: INTRODUCTION TO PROTEIN SENSING USING A NANOPORE 
1. P is for Protein  
Proteins play critical roles in all aspects of life. Proteins consist of amino acids as 
their fundamental building units, and the sequence of which is referred to as the primary 
structure.1 These chemically precise macromolecules fold locally and globally into 
secondary and tertiary three-dimensional structures in aqueous solution to afford 
biochemically active entities. Proteins engage with other biomolecules through specific 
physicochemical interactions at their surface, and these interactions are dependent on the 
protein’s structure and composition. These interactions dictate the selectivity, the time, and 
the strength of interaction(s), which enable the diversity of protein functions from 
structural, organizational, manufacturing, to signaling. For example, vascular endothelial 
growth factor (VEGF) is normally expressed in embryo as well as in cancerous tissue. Its 
bioactivity is concentration dependent as it forms monomer at low concentration (< 1 nM) 
but forms bioactive dimeric species at high concentration.2 Study of the protein structure 
in solution is key to understanding its biological role as well as to identifying new 
diagnostics and treatments for diseases. 
Proteins are abundant in our daily life, for example, we observe protein albumin in 
egg white transforms from a clear liquid to white solid during cooking (or heat-induced) 
denaturing process. In a research setting, the structures and compositions of proteins are 
analyzed using a variety of biochemical and biophysical techniques. Edman Sequencing is 
the gold standard to determine a protein’s primary structure, and it involves digesting the 




sequence and any post-translational modifications, such as glycosylation.1 X-Ray 
crystallography, nuclear magnetic resonance (NMR) spectroscopy, circular dichroism, and 
infrared spectroscopy are all common methods to assess a protein’s secondary structure 
including alpha helices, beta sheets, beta turns, and random coils. The spatial relationships 
between the secondary structures of a protein define its tertiary structure, which X-ray 
crystallography and NMR spectroscopy are often used to characterize. Finally, the 
quaternary structure reflects multiple folded subunits into a larger oligomeric complex. 
Similarly, techniques like X-ray crystallography and NMR spectroscopy are extensively 
used along with newer methods such as cryo-electron microscopy to elucidate the 
quaternary structures.3 The above techniques directly determine the protein composition 
and structures. There are also indirect methods, whereby a spectroscopy probe(s) attached 
at a specific site(s) on a protein provides a signal in response to folding, binding with 
another protein, post-translational modification, or oligomeric states.    
Although the above techniques are widely used and valued in protein 
characterization, these bulk measurement or ensemble-averaged techniques do not enable 
us to address a number of critical questions, such as obtaining dynamic structural 
information on a protein (or its reaction or binding with another protein) in real-time. 
Moreover, for an effective analysis, bulk methods require large copy number of identical 
proteins, not readily available in many clinical and biomedical relevant cases. Hence the 
ability to analyze proteins at the single molecule level opens up new avenues for protein 
based molecular diagnostics. Investigating proteins at the single-molecule level is of 




of the stochastic nature of chemical processes; and 3) an overview of the heterogeneity 
across a population of molecules.  
To address these challenges as well as future questions, single molecule protein 
sensing techniques have been developed, which include advanced optical microscopy 
techniques, optical/ magnetic tweezers, atomic force microscopy (AFM), microcantilevers, 
nanochannels, and nanopores. In particular, the development of total internal reflection 
 
Figure 1. Protein biochemical/biophysical information that could be obtained from a 
nanopore sensor and the NP data that provide such information. The information is ranked 
according to its length scale. For example, the concentration of the protein in bulk solution is 
obtained by measuring the arrival rate.4 Combining with an ability to sense the volume of an 
individual analyst, NP could measure a protein’s binding kinetics2,5, oligomeric formation6 and 
aggregation kinetics.7 Once the pool of events are collected, the information about protein’s 
diffusion coefficient, overall charge, volume and shapes could be estimated.8 Sub-nanometer 
nanopore could be used to sense a chemical information within the protein molecule such as its 
unfolding pathway,9,10 domain structures,2,5,11 post-translational modification,12 mutation,10 and 
peptide sequences.13,14 The major advantage of nanopore is that it is a single-molecule technique, 




fluorescence microscope (TIRF), a zero mode waveguide, in a combination with 
fluorescence resonance energy transfer (FRET) techniques, allow an optical detection and 
structural characterization of an individual labeled molecule near surface. Single molecule 
force spectroscopy techniques such as optical tweezers, magnetic tweezers, and atomic 
force microscopy (AFM) are providing information on the folding and unfolding of protein 
 
Figure 2. A schematic view of single-molecule nanopore sensing techniques. (a) Ions flow freely 
across the nanopore due to an applied electric field. Physical blockage of a protein of interest obstructs 
the ion flow, resulting in a drop in the pore’s current. Restoration of the pore’s current once the protein 
leaves the pore. (b) Representative event as a result of single protein translocation. (c) Nanopore sensor 
experimental setup. The nanopore sensor resides in a Faraday cage to prevent the external noise. The 
sensor is connected to the headstage which transduces the current signal to the amplifier and to the data 
acquisition (DAQ) card. The data is then processed using a program to extract the nanopore event from 




structures as a function of applied external force and the binding strength between a protein 
and its partner ligand. Current emerging single-molecule techniques used to study proteins 
are reviewed elsewhere.15 Among these techniques, nanopore sensing is at the forefront. 
Nanopores are widely used to characterize DNA,16,17 proteins, and DNA/protein 
complexes.18,19 The successful commercialization of a nanopore for DNA sequencing 
(Oxford Nanopores’ MinION) represents a significant milestone in the field, demonstrating 
the translatability of this technology.17 The potential applications of native, unmodified, 
protein nanopore sensing include the opportunity to: 1) detect and quantify concentration 
of a protein(s) in solution; 2) analyze protein size and charge; 3) monitor binding 
interactions or reactions between proteins or a protein and a ligand to afford kinetic and 
equilibrium data; and 4) resolve conformational changes in structure.  
 
Figure 3. Cartoon illustrating 
nanopore operation. Translocating an 




2. N is for Nanopore sensor  
A nanopore sensor consists of a nanometer-sized pore (i.e. 1-100 nm in diameter) 
embedded or made in an insulating membrane that separates two chambers containing an 
electrolyte solution. When an electrical bias is applied across the membrane, ions flow 
freely through the pore producing a constant open pore current. The flow of ions is partially 
impeded when a biomolecule diffuses through the pore or translocates from one side to the 
other under the influence of a driving force, thereby changing the ionic current. Figure 2 
depicts schematically the fundamentals of the nanopore sensing technique. The principles 
of operation are reminiscent of a classic Coulter Counter. However, the nanopore sensor 
provides enhanced sensing capability at the single molecule level due to its nanoscale 
dimension. Proteins are typically 2-10 nm in size. When the size of the pore is comparable 
to the size of the analyte, the change in ionic current is more prominent than when using a 
larger pore (see figure 3 for an analogy).  
2.1 Nanopore types – biological and synthetic 
Nanopores are broadly categorized into two main groups: biological and synthetic 
pores. The first nanopore for single-molecule detection used a biological protein pore, α-
hemolysin, for DNA detection16 and later on for protein sensing applications.20 The device 
is composed of a single recombinant protein pore embedded in a lipid bilayer. More 
recently, additional protein pores such as MspA,21 ClyA,5 aerolysin,14,20 Nfp,22 and FraC23 
have been evaluated. The advantage of protein nanopores include their well-characterized 





Table 1. The four main categories of nanopore sensors (drawings are not to scale) 
 
 Synthetic nanopores13,19,24–26 generally exhibit greater mechanical robustness, 
control over pores’ geometry and its surface chemistry. Solid-state nanopores can 
fabricated by electron-beam drilling,27 ion beam sculpting,28 controlled dielectric 
breakdown,29 or even direct laser drilling.30 Advances in micro-nanofabrication are also 
enabling the fabrication of single-atom layer nanopores from 2D materials such as 
Type of 
nanopores 
Features Advantages Challenges 
Protein pore 
 
 A biological protein pore 
suspended on a lipid 
membrane 
 Recombinant protein 
synthesis technique 
 e.g., α-hemolysin,16 20 
MspA,21 ClyA, 5 
Aerolysin,14,20 Nfp,22 FraC23 
 Well-defined 
sensing region 
(typically 1-2 nm in 
diameter, ~1 nm 
thickness) 
 Highly repeatable 
 Low electrical 
noise 
 Constraint pore 
geometry and surface’s 
chemical properties 
 Not compatible with 
the harsh chemical 
environment 
 Poor mechanical 




 Small hole embedded in a 
free-standing membrane on 
a silicon chip 
 Milling by electron beam 
or ion beam, dielectric 
breakdown 
 e.g., SiNx,19,24 HfO25 
 Flexible 
geometrical design 
(1-100 nm in 
diameter, down to a 
few atomic layer 
thickness)  
 Surface chemical 
control 
 Expensive and slow 
fabrication 
 Controlling the pore’s 
shape is tricky  
2D material pore 
 
 Small hole embedded in a 
free-standing membrane on 
a silicon chip 
 Milling by electron beam 
or ion beam 
 e.g., graphene,26 MoS213 
 High sensitivity 
(ideally at single-
atom level) 
 Limited surface 
chemical modification 




 A glass capillaries with a 
tapered end 
 Pulling a glass capillary 
followed by electron beam 
sculpting 
 e.g., borosilicate31 
 Ease of 
fabrication  
 
 Restricted pore size 
(usually >50 nm size-






13  Last but not least, glass nanopores are fabricated by pulling a 
glass capillary to produce a taper end followed by electron beam sculpting to afford a 
narrow pore opening at the end.31 The advantage of using a glass nanopore is the ease of 
fabrication compared to other synthetic pores, however, fine-tuning the pore’s diameter 
down to sub nanometer level is challenging. We refer the reader to the following reviews 
which focus specifically on nanopore fabrication.32,33  
2.2 General considerations for sensing single molecules: sensing region and 
resolutions 
In single-molecule nanopore sensing, the pore’s geometry is chosen to be 
comparable with the cross section of the biomolecule of interest to maximize the change 
in ionic current during a translocation event and ultimately, maximize the signal-to-noise 
ratio. Typically, a translocation event is measured by the fractional event amplitude, 
defined as a ratio between the change in blocked current and the open pore current (iB = 
ib/io). In a first approximation, the fractional event amplitude was shown to be proportional 
to the physical blocking volume of the analyst over the sensing volume of the pore.34 For 
example, doubling the diameter of the pore will decrease the fractional event amplitude by 
four times since the open pore current increases quadruple-fold. In general, the open pore 
current is expressed as:35 
iopen = VG = Vσ[(4l/πd
2) +(1/d)]-1     (1)  
where V is the voltage bias and G is the pore’s conductivity. The first term of the 
conductivity σ (πd2/4l) arises from the geometrical constraint of the pore itself (assuming 




results from the ionic current converging from the bulk solution into the pore’s vicinity. 
For instance, a synthetic pore of 4 nm in diameter and 10 nm in thickness, immersed in 1 
M KCl solution (bulk conductivity σ = 10.5 S m-1) under a bias of 300 mV will generate 
an open pore current of 3.7 nanoamperes. 
The narrowest region of the pore is where the sensing occurs as this in the area with 
the largest electric field drop. In an α-hemolysin pore, this sensing region is estimated to 
be ~6 nm of the β-barrel’s length, while the entire pore length is 10 nm.36 An electron-
beam sculpting solid-state nanopore usually possesses a double-conical shape, and thus, 
the effective pore’s length is smaller than the film’s thickness. This dimension can be 
estimated, experimentally, by characterizing the translocation of a well-known analyte 
such as DNA. A narrow sensing region is desired in order to resolve the molecular features 
of the analyte such as resolving a protein’s domain.37 However, a drawback is that thin 
pores exhibit lower mechanical stability and translocation of the analyte is fast. As a result, 
many of the events may not be resolved within the experimental limited temporal 
bandwidth.  
Capturing the nanopore signal requires a sufficient temporal bandwidth. For 
example, for a typical translocation dwell time of 1 µs the system bandwidth should be at 
least 1 MHz. However, using a high bandwidth system can be tricky as the membrane noise 
grows rapidly at high frequencies due to capacitance noise terms that can obscure the 
proteins translocation signals. As a result, 10 - 100 kHz acquisition bandwidths have often 
been used in nanopore sensing despite capturing only a fraction of the events. 




electrical noise. The signal-to-noise ratio, typically defined as (io-ib)/io, where ib is the 
blocked pore current and io is the open pore current, correlates to the spatial resolution. A 
typical reduction in the pore current during protein translocation is ~ 0.5 nA associated 
with a typical root-mean-square (RMS) noise of ~ 0.1 nA measured at a bandwidth of 100 
KHz, gives SNR of ~5. 
If the signal generated by a protein is close or smaller than the RMS level, the 
translocation events cannot be differentiated from the background noise. The overall noise 
in the system originates from both the electrical sensing circuit (amplifier’s internal circuit, 
choice of filters, charge transfer at the electrodes, etc.) and the nanopore sensor’s physical 
characteristics (membrane material and composition, charge, capacitance, etc.).  
3. A is for Analysis  
3.1 Understanding the nanopore signal generated from proteins 
Characterizing and understanding the physical principles governing protein 
translocating through a nanopore and yielding an ion current signal is an ongoing 
challenge. The most straightforward model is that a protein translocates through the pore 
as a fully-intact protein, similar to a cell translocating through the several hundred micron-
sized pore of a traditional Coulter Counter (Table 2 – first entry). However, protein 
molecules are subjected to significant forces of physical, electrical, and chemical origins 
while traversing through the nanopore. As a result, the protein may: 1) undergo structural 
changes such as partly unfolding,39 or fully unfolding;9,10 2) not translocate smoothly but 
rather tumble;8 3) temporarily or permanently absorb38,40 onto the pore walls; or 4) 




Table 2. What happens when a protein entering a pore   





Deep event amplitude  
 












 Introduce denaturing agents 
such as SDS or urea 
 increase voltage/ shorter 
dwell time9,10,39 
Adsorption to a pore’s 
wall 
 
Deep events, millisecond- 
to second long 
 
 pretreat the pore’ wall with 
a lipid or a surfactant38,40 
Tumbling inside a pore 
 
Strong intra-event signal 
fluctuation 
 
 Introduce strongly-charged 






of these events may happen resulting in various characteristic signal signatures. Table 1 
summarizes possible mechanisms, signal characteristics, and recommendations as to how 
to match a particular signal event with a translocation or other pore event(s). Note that this 
is just a set of guidelines, and ultimately the analysis will require a thorough series of 
experiments. 
3.2 Regulating the nanopore event: voltage, pH, ionic strength, temperature, 
surfactant, protein concentration  
Proteins are drawn and translocated through the nanopore as a result of 
electrophoretic, electroosmotic and in some cases thermophoretic forces. The nanopore 
also can serve as a physical barrier to facilitate the unfolding of protein, especially when a 
pore’s diameter is comparable or smaller than the size of a solvated protein.10 The voltage 
bias directly determines the electrophoretic force: a larger voltage bias facilitates the 
translocation (shorter dwell time) of a protein with the opposite charge. The voltage bias 
also increases the flow of counter ions due to electroosmotic force, which may facilitate or 
hamper the translocation of a protein depending on the direction of water flow.23 A stronger 
force favors protein shearing or unfolding, resulting in a shallower event amplitude and 
longer translocation time.42 Nanopore-induced protein denaturation is naturally stochastic, 
resulting in broad signal distributions.  
To promote protein linearization prior to translocating through the pore, the 
unfoldase protein has been anchored to the pore’s mouth to afford a signal with unique 
patterns corresponding to different proteins.9 Strong denaturants are also used to denature 




hydrochloride,42 urea,10  or sodium dodecyl sulfate (SDS)42. Surfactants will form a 
monolayer coating the pore’s wall, and, thus, reduce the pore’s effective diameter while 
minimizing non-specific adsorption of a protein onto the pore’s wall similar to lipid-coated 
pore.7  In the later strategy, Yusko et al, pre-treated 6 – 65 nm silicon nitride pores with an 
aqueous suspension of small unilamellar liposomes, creating a bilayer coating which 
increases the nanopore’s overall resistance. The protein analyte was anchored with the lipid 
molecule and diffused through the pore governed by the high viscosity of lipid membrane 
rather than the low viscosity of the aqueous electrolyte in the pore.   
Temperature affects the protein translocation through the nanopore in various 
aspects. First, a higher temperature promotes ion diffusion, hence the open pore current 
increases while the noise remains similar.20 When a protein such as a maltose binding 
protein, MalE219, enters the NP, the observed event arrival rate increases as a function of 
temperature, which is likely due to the enhancement of thermal motion.20 The increase in 
the protein’s diffusion coefficient results in faster translocations through the nanopore. 
Further heating the nanopore system up to 70 °C affords a temperature-induced unfolding 
of the protein.20  
Because a protein is an amphiphilic molecule with ionizable amino acids, its overall 
charge depends on the pH of the solution, which in turn affects the electrophoretic force 
acting on the protein. The isoelectric point (pI), the overall charge of the protein when 
equal to zero, depends on its amino acid sequence and post-translational modifications. At 
a pH less than the pI, the protein is positively charged and therefore is drawn across the 




the protein’s overall charge changes resulting in a significant raise in the translocation 
dwell time.  The change can be quite significant -- more than a 2-3 order of magnitude 
change in the dwell time when the pH is roughly 0.2-0.3 units away from the pI.11 By 
performing nanopore sensing experiments across a series of pH, the precise isoelectric 
point of each molecule is determined similar to the isoelectric focusing technique. 
However, as the pH of the solution approaches the pI the protein has almost zero net charge 
and aggregations are likely to form with few translocations.  
In the case where the analyte has a strong dipole moment, a protein will enter the 
nanopore and translocate in a preferred orientation. For example, a multilevel translocation 
signal is observed with the protein/DNA chimera between thioredoxin and DNA 
translocates the pore under a positive bias. The event profile corresponds to a signal of the 
densely negatively charged DNA follow by a positively charged protein.10 Another 
interesting translocation profile is observed with a linearized amphiphilic peptide which 
gives a ratcheting motion or molecular stalling effect as a likely effect of the presence of 
localize charge on the adjacent segments affording a molecular tug-of-war effect.24 
3.3 Controlling a protein detection rate 
The signals obtained from one single molecule measurement are subject to 
statistical fluctuations since natural phenomena are usually governed by Poisson noise. 
Thus, it is important to collect a significant number of events, usually a few hundred up to 
thousands of events, and perform statistical analysis.15 Large data set requires longer time 
to collect the data, depending on the protein detection rate. 




strategy is to employ the biophysical properties of the nanopore and protein to enhance the 
capture rate including the use of dielectrophoretic trapping with a salt-gradient in a glass 
nanopore.4 A second strategy employs various types of ligands as carriers for the proteins 
of interest. Some common biomacromolecular carriers are DNA and RNA. In contrast to 
proteins, DNA and RNA molecules possess a uniform distribution of negative charges and 
therefore their translocation events are relatively easy to study and predict. Several studies 
have reported the successful use of these carriers to identify proteins using 
unfunctionalized solid-state nanopores. For example,  Niedzwiecki et al. demonstrated the 
use of an RNA aptamer, stem-loop 3 ( SL 3) , to detect a protein biomarker of the human 
immunodeficiency virus ( 1HIV-)1, nucleocapsid protein ( 7NCp)7, using silicon nitride 
nanopores.43 Upon applying a positive voltage, no translocation of NCp 7was observed due 
to its net positive charge. When a negative voltage was applied, the proteins absorbed onto 
the surface of the inorganic silicon nitride surface, and translocation was thus hindered. 
However, when the NCp 7 protein was bound to an SL 3 aptamer, well-defined 
translocation events with distinguishable current blockades from the free NCp7 were 
observed, allowing the researchers to measure the dissociation constant of the two 
biomacromolecules. In addition to RNA aptamers, Bell and co-worker reported the use of 
a DNA carrier to detect various proteins with high specificity.31 The DNA carrier used in 
the study was a seven kbp double-stranded DNA with evenly spaced nicks on one strand, 
which allowed for chemical attachment of functional motifs at the 3 ’ or 5 ’ end. When 
biotins were conjugated to the DNA carriers, streptavidin molecules were able to 




events. Whereas unmodified DNA carriers and biotin-conjugated DNA carriers, without 
exposure to streptavidin, afforded mainly single-step translocation events. 
3.4 Signal processing basic measurement: capture rate, dwell time, and event 
amplitude 
The three basic nanopore event characteristics are capture rate, dwell time, and 
event amplitude. The capture rate is the rate at which the nanopore event occurs, obtained 
by measuring the inter-event interval (ti, see fig 4a-b) and using its histogram to fit with 
the exponential decay function.44 The nature of protein capture rate is stochastic and is 
classified based on two mechanisms: 1) a protein diffuses from bulk solution and is trapped 
in the electric field generated near the pore’s vicinity following the Smoluchowski’s rate 
equation; and, 2) a protein overcomes an entropic barrier and enters the pore funnel under 
electrophoretic and electroosmotic forces.45 The two mechanisms depend on the protein’s 
bulk concentration as well as its biophysical properties such as diffusion coefficient, 
charge, size relative to the pore. These dependencies imply that the capture rate can be used 
to measure the analyst’s bulk concentration (if the biophysical properties are known or the 
concentration/capture rate curve is established) or, vice versa.  
The nanopore event’s mean residual current, so called event amplitude, is 
proportional to the physical blockage of the ionic flow due to a presence of the particle 
amplitude (fig 4c). The event amplitude is often normalized to the open pore current for 
pore-to-pore consistency. If one consideres a protein as a non-deformable charged particle, 
an approximate model relates the protein’s excluded diameter (dm) inside the pore’s 






      (2) 
This equation shows the relationship between the fractional event amplitude (ΔI/IO) 
and the protein’s diameter (dp) and its sensing region’s height (heff). However, this model 
involves the following assumptions.  First, the particle is assumed to have a uniform 
spherical shape. Second, the particle size is comparable to the height of the pore (yielding 
the shape correction factor of 0.8). Third, when the protein traverses the pore, it carries a 
thick solvation layer of non-mobile ions and water molecules, thus complicating the 
estimation of the effective excluded volume directly from the protein’s crystal structure.  





Figure 4. Basic nanopore signal processing. Example translocation of a model protein. (a) 
Representative current trace (I) as a function of time (t). Each drop in current is defined as a 
nanopore event. (b) The time between the start of each event is inter-event interval (ti), which 
could be fitted by exponential decay function. (c) The event dwell time (tD) histogram is fitted by 
either drift-diffusion model or exponential decay function. (d) The ratio between event amplitude 
(Ib) and open pore current (Io) is fitted by multimodal distribution. (e) The scatter plot of Ib/Io vs 




Last but not least, the dwell time, defined by the time elapsed between the initial 
drop in the ion current to its return above the same level, is a reflection of the time the pore 
spends in the pores sensing volume. Typically, the dwell time decays exponentially with 
the applied voltage, hence performing measurements at several applied voltages is an 
effective way to discern the true translocation events from short collisional events. The 
dwell time distribution contains information about the protein’s charge, mobility, and 
diffusion coefficient. Typically, the dwell time distribution is tail-fitted by an exponential 
decay function to provide a characteristic time scale. In some cases a diffusion-drift model 
may be used to fit the date, although caution should be exercised when interpreting the 
meaning of the diffusion constant, D, and the proteins mobility, ν, inside a narrow pore, as 
these include interactions with the pore itself, in addition to the normal solution friction:25 
     (3) 
The physical confinement and the interaction between the protein and pore’s wall 
also can be theoretically related under some approximation to D and ν.46 
3.5 Advanced signal analysis: subevent information 
Complex structural motifs affecting the local size (cross-section) of proteins may 
result in long ion-current blockade events consisting of multiple subevent current levels. 
To analyze such events, all data point histogram is plotted to identify if there are multiple 
sublevels. Each difference in sublevel must be larger than the current noise to be resolved. 
The sublevel identification and pattern recognition is done manually9,10 or by an algorithm 
such as edge-finding (similar to the one used in analyzing single-molecule FRET data).19 




will play a crucial role in understanding nanopore signals generated from proteins. The 
current fluctuations during the event, the noise of the residual current is used to detect post-
translational modification on the protein.12 The distribution of an event amplitude 
histogram describes the natural fluctuation of the protein inside the pore, which is related 
to its overall gross shapes (e.g., prolate or oblate ellipsoid), its dipole moment, and its 
rotational diffusion coefficient. Up to five parameters can be obtained to classify a 
protein.8,41 Furthermore, the current fluctuations during the event, the noise of the residual 
current also sensitive to the biochemical properties of the protein such as mutation and 
post-translational modification,12 which we will cover in the later section.  
4. E is for Examples 
The following examples showcase the capabilities of nanopores for sensing and 
characterization of proteins. For a comprehensive review of single-molecule protein 
sensing in a nanopore, we refer the readers to several excellent reviews.37,47,48 In the 
following examples, we describe the use of nanopores to: 1) probe binding affinity; 2) 
characterize protein domains and oligomeric states; 3) study protein unfolding; 4) detect 
specific sites of phosphorylation on a protein; and 5) identify biomarkers and peptide 
variants. 
4.1 Probing binding affinity  
Nanopore sensing is a useful tool for the study of biomolecular complexes 
consisting of two or more biomolecules. Squires et al. investigated the binding between 
DNA and a classical transcription factor (TF) using a solid-state nanopore.19 Binding 




thus understanding these interactions provides valuable insights into the genetic regulation. 
In this study, the well-characterized zinc finger protein, zif268, also known as early growth 
response protein 1 (EGR-1), binds a 1 kbp DNA fragment containing only one binding site 
for zif268. Upon translocation, five distinct event patterns based on different steps found 
in subevent were categorized. Zif268 binds to the DNA via two different states, a specific 
recognition state and a non-specific search state. When zif268 specifically binds to the 
DNA in the recognition state, all three zinc finger domains were bound to the major groove 
of the DNA. Whereas in the non-specific search state, one of the zinc finger domains was 
positioned away from the DNA and the TF was able to slide easily and quickly along the 
DNA. Using the translocation data of the zif268 + DNA complex, different subgroups of 
translocation events are associated with the recognition and search mode of zif268 
respectively. In the recognition state, translocation of the zif268 + DNA complex produced 
an ABA pattern event as shown in Fig. 5, top panel.  Blockage at level A represented the 
strand of DNA and a deeper level at B resulted from the tightly bound zif268. In the search 
state, translocation of the DNA-TF complex led to the event with AC pattern (Fig. 5, 
bottom panel). Similar to the recognition state, level at A was associated with the DNA 
backbone and a deeper blockage of level C compared to level B could be explained by the 




4.2 Characterizing protein domains and oligomeric states 
In biological systems, proteins can exist in different oligomeric states, and some 
proteins possess multiple domains or secondary/tertiary structures. Protein oligomers are 
often connected by disulfide bonds, and different domains within a protein exhibit distinct 
structures and functions. Several studies have elucidated the different domains and 
oligomeric states of proteins using nanopores.2,9 Nivala et al.,9 examined three variants of 
an ubiquitin-like protein (Smt3), all of which were conjugated to a negatively-charged 
polypeptide tails to aid in nanopore translocation with an applied  postive bias and an 
unfoldase protein coupled to an α-hemolysin pore  (Fig. 6a). Variant i had one unit of Smt3, 
and variant ii and iii each had two units of Smt3 separated by a short and long linker, 
Figure 5. Probing binding states between DNA and TF using a solid-state nanopore. The 1 
kbp DNA contains one binding site for TF zif268. When the TF binds to the DNA specifically (top 
panel), the DNA backbone leads to a current drop from io to iA and a deeper blockage level at iB 
represents the tightly bound TF. In the non-specific binding state (bottom panel), the TF slides 
along the DNA backbone, creating a distinct blockage level at iC. Adapt with permission from A. 





respectively. Translocation of these three variants produced distinct sub-event levels and 
residence times which correlated with their three-dimensional structures. Another study by 
Varongchayakul et al.,2 focused on studying dynamics of monomer, dimer, and trimer 
vascular endothelial growth factor (VEGF), which are held together via disulfide linkages. 
Each VEGF structure produced a unique event amplitude, with monomers affording the 
smallest blockage level and trimers giving the largest (Fig. 6b). After the addition of tris(2-
carboxyethyl)phosphine (TCEP), a commonly used disulfide bond reducing agent, to a 
solution containing a mixture of VEGF structures, the majority of  translocation events 
exhibited a small blockage level consistent with a VEGF monomer population present. 
When the enzyme plasmin cleaved the receptor recognition and heparin-binding domain 
of VEGF, the positively charged heparin-binding domain gave single-level events with 
lower amplitude compared to events before cleavage when a negative potential was 
applied. When the potential was switched across the membrane, the negatively charge 
receptor recognition domain translocated with single-level events detected. 
4.3 Exploring nanopore-induced protein unfolding  
When the diameter of the nanopore is smaller than the diameter of the protein 
molecules, the protein may undergo structural deformation such as partial or complete 
unfolding in order to traverse the pore. In the reported translocation event that corresponds 
with construct i shown in Fig. 6a, several distinct sub-events are observed with different 
amplitudes and dwell times.10  These sub-events are correlated to different stages of 
translocation in an α-hemolysin pore. The protein substrate, in this case, is tagged with a 





molecule when a potential is applied. Once the polypeptide tail traverses through the pore, 
the unfoldase-targeting sequence on the tail is recognized by the ClpX unfoldase protein in 
the trans chamber and the protein is then unfolded and threaded through the pore. Stage 1 
shows the open-pore current before the capture of the protein. When the linear polypeptide 
tail enters the pore, the ion flow decreases immediately, creating a sharp drop in current as 
shown in Stage 2.  Upon recognition between ClpX unfoldase and the polypeptide, the 
current drops further in Stage 3. The potential and unfoldase-driven force continues to pull 
on the protein, causing it to gradually unfold, enter and exit the pore, leading to a period of 
 
Figure 6. Characterization of protein (a) domains and (b) oligomeric states using nanopores. 
In the example shown in (a), three variants of Smt3 protein were labeled as i, ii and iii shown on 
the left. Their corresponding translocation events revealed multiple ionic current blockage levels 
on the right. The sub-events were categorized into 7 stages, with stage 4 and stage 7 representing 
the translocation of the unfolded Smt7 protein. The events shown in (a) are also examples of 
nanopore-induced protein unfolding discussed in section 4.3. Adapted with permission from J. 
Nivala, D. B. Marks, and M. Akeson, Nat. Biotechnol., 2013, 31(3), 247–50. Copyright 2013, 
Nature Publishing. In (b), the monomeric, dimeric and trimeric VEGF proteins exhibited 
moderate (yellow), intermediate (red) and deep (blue) current blockage levels that correspond to 
their sizes. After the addition of TCEP, a reducing agent of disulfide bonds, the dimeric and 
trimeric VEGF proteins were converted into the monomeric state. Adapted with permission from 
N. Varongchayakul, D. Huttner, M. W. Grinstaff, and A. Meller, Sci. Rep., 2018, 8(1), 1017. 




deep current blockage in Stage 4. Once the protein leaves the pore, the open-pore current 
returns to the same level in Stage 1. The magnitude and duration of each level in these 
subevents can further reveal the structural and functional information of the proteins.21  
4.4 Detecting post-translational modification 
After translation, a protein may undergo post-translational modification(s) such as 
phosphorylation, acetylation, and glycosylation. These modifications are critical to the 
function of the mature, native protein. To determine if a nanopore sensor detects these fine 
features of protein primary structure at the single-molecule level, Rosen and co-workers 
investigated the phosphorylation of a model protein thioredoxin (Fig. 7).12 Thioredoxin 
contains two phosphorylatable sites at position 107 and 112. To facilitate nanopore sensing, 
they conjugated a 30-mer oligonucleotide to the C-terminus. Upon applying a potential 
across the nanopore with a positive bias at the trans chamber, the negatively charged 
oligonucleotide guided the oligonucleotide-protein conjugate to the pore for subsequent 
translocation. During the translocation, thioredoxin unfolds, and a  multi-level current 
pattern is observed. The four constructs of thioredoxin, containing the combinations of 
native and phosphorylatable sites, gave unique translocation signature elucidated by the 
scatter plots of the mean residual current (Ires) vs. subevent noise (In) for different 
phosphorylation states shown in Figure 7.  
4.5. Identifying biomarkers and peptide variants 
Nanopore technologies have been widely explored for applications in nucleic acid 
sequencing in the past decade. Recently, research efforts are directed at nanopore sensing 





Fragaceatoxin C (FraC) nanopores to identify a variety of proteins with size ranging from 
1.3 kDa to 25 kDa.23 When these proteins were analyzed independently, the translocation 
events were compared based on the dwell times and the fractional event amplitude 
(expressed in percent Ires%). The events corresponding to each protein clustered around a 
certain region on the dwell time vs Ires% plot. When a mixture of three different proteins 
(2-microglobulin, human epidermal growth factor and endothelin 1) was investigated and 
analyzed, based a dwell time vs Ires% diagram, the event cluster corresponding to each 
 
Figure 7. Detecting thioredoxin protein in native and three different phosphorylation states 
using an α-hemolysin nanopore. The red circles signify the number and position of 
phosphorylated residues on the protein. Each protein is also tagged with a 30-mer oligonucleotide 
to the C-terminus to facilitate translocation. The scatter plot of the mean residual current (Ires) vs. 
subevent noise (In) of the four thioredoxin constructs revealed four unique populations 
highlighted in blue, green, black and red, which correspond to the native and three different 
phosphorylation states of thioredoxin. Adapt with permission from C. B. Rosen, D. Rodriguez-





protein produced a distinct population on the plot. Thus, these proteins are discriminated 
from each other based on the translocation data. Furthermore, when comparing the 
translocation events of endothelin 1 (ET-1) and endothelin 2 (ET-2), it was possible to 
distinguish these two peptides from each other even though these two peptides only differ 
by 1 amino acid out of 21 in their sequences (Fig. 8).  This remarkable sensing specificity 
 
highlights the potential of nanopore sensing for identifying proteins in a mixture. In 2018, 
Piguet et al., used a wild-type aerolysin nanopore to identity a single amino acid variant in 
uniformly charged homopolymeric peptides.14 First, arginine peptides of 5-10 amino acids, 
which differed by a single amino acid in length, were introduced to the pore. Unique 
amplitudes (Ib/Io) and durations were observed. The 10 amino acids long lysine 
 
Figure 8. Distinguishing endothelin 1 (ET-1) from endothelin 2 (ET-2) using a 
Fragaceatoxin C nanopore. (a) The translocation data of ET-2 and ET-2 revealed 
distinguishable current blockades with Ires% at 8.9 for ET-1 and Ires% at 6.1 for ET-2. (b) By 
adding ET-1 and ET-2 consecutively to the same pore, two distinct populations were observed 
by plotting the event amplitude standard deviation over the corresponding Ires%. Adapt with 
permission from F. Piguet, H. Ouldali, M. Pastoriza-Gallego, P. Manivet, J. Pelta, and A. 




homopeptides show different blockage current compared to the arginine homopeptides of 
the same length. Additionally, the event population shifts toward shorter species upon 
addition of trypsin enzyme. The mixture of two homopeptides were also discriminated at 
single-molecule resolution. Finally, a heteropolymer of 5 lysine amino acids and 5 arginine 
amino acids displayed unique event amplitude upon comparison with the homopolymers 
of arginine or lysine. These two reports reinforce the promising ability of a nanopore to 
sense a difference at the single amino acid level. 
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CHAPTER 2: SENSING NATIVE PROTEIN SOLUTION STRUCTURES USING 
A SOLID-STATE NANOPORE: UNRAVELING THE STATES OF VEGF   
1. Introduction  
Cytokines are small signaling proteins that mediate cell-cell communication 
involved in infection, immune response, inflammation, trauma, transplantation, 
degenerative age processes, and cancer1–4. Many cytokines have emerged as important 
therapeutic targets or as predictive or prognostic biomarkers. Nowadays, the gold standard 
method used to quantify cytokines in solution is enzyme-linked immunosorbent assay 
(ELISA), which relies on target recognition based on antibody specificity and sensitivity5. 
Vascular endothelial growth factor (VEGF), is one of the most well studied cytokines due 
to its pivotal role in stimulating vascularization and angiogenesis, in normal as well as in 
patho–physiological processes, such as cancer6–12. VEGF compromises of a family of 
proteins: VEGFA, VEGFB, VEGFC, VEGFD, and placental growth factor. The principle 
mediators of tumor angiogenesis are the soluble VEFG121 and VEGF165, which are both 
isoforms of VEGFA, produced by alternative splicing. VEGFA isoforms are important 
therapeutic targets for inhibition of angiogenesis and cancer treatment, although their role 
as predictive biomarkers for certain cancer types has yet to be established13. The longer 
isoform, VEGF165, is the predominant form. Since VEGF165 is the focus of our study, for 
simplicity it will be referred to as VEGF from now onwards. VEGF consists of two 
domains: the VEGF1-110 receptor recognition domain
14 and the VEGF111-165 heparin binding 
domain15, linked by a plasmin cleavable flexible segment16,17. The disulfide bonds of 




of VEGF to form homodimers18. Thus, obtaining tertiary and quaternary structural 
information on VEGF in solution (both statically and dynamically) may be of medical 
relevance and interest. Herein, we investigate the conformational landscape of VEGF 
multimers using solid-state nanopores (ssNPs). Specifically, by exploring the effect of 
reducing agents and reaction with plasmin enzyme, we show that VEGF dimerization 
dynamics and structure are directly probed by the nanopore, obviating the need for 
antibodies or specific protein labeling. Furthermore, we relate the step-like features present 
in the ion-current traces during VEGF translocation to the structural domains of VEGF. 
Nanopore (NP) sensing is an advanced technique for biomolecular characterization 
at the single-molecule level that uses either a biological or a solid-state NP19,20. In a NP 
setup, an applied electrical voltage produces a strongly converging electric field near the 
pore’s vicinity. This voltage produces an ion current through the pore that can be measured 
using a sensitive electrometer. Charged biomolecules are subject to an electrophoretic force 
that draws them towards the NP21. Upon capture, the biomolecule electrophoretically 
threads through the pore partially blocking the ion current. NPs have been used to 
characterize proteins by resolving their size22–25, charge26, post-translational 
modifications27–30, specific interactions with an antibody or DNA31–33, aggregated state34, 
or a combination of them35,36. However, NP detection of multimeric proteins has remained 
elusive to date, partly due to the multiple conformations that these complexes can exhibit 
in solution, which leads to complex ion current signatures and broad translocation dwell-





2. Experimental Section 
Nanopore fabrication and drilling. Nanopore chips were fabricated as previously 
described.32 In brief, silicon wafer coated with 500 nm SiO2 (Virginia Semiconductors) and 
low-stress LPCVD amorphous silicon nitride (SiNx: 50 nm, Cornell CNF) were used. The 
SiNx was locally thinned to 7-12 nm in ~2 µm circular wells, using a lithographic-mask 
whole wafer protection followed by reactive-ion etching. Then the silicon wafer is etched 
through with KOH, leaving a free-standing membrane of SiNx with a thinned area in the 
center of the window. NPs were drilled through SiN using highly focused transmission 
electron microscope (JEOL 2010 FEG) to sputter away materials from the thinned 
membrane. Pores of 4-6 nm could be formed within 1 minute of focusing the beam. Unless 
otherwise stated, we used 5.5 nm diameter ssNP fabricated in a 12-nm thick SiNx 
membrane. Since small pore-to-pore variations in diameters can bias the classification of 
translocation events amplitude, we performed each set of experiments using the same NP 
device and discarded data in which pores expanded during a given measurement. 
Protein sample. VEGF used in this study was a recombinant human protein 
purchased from Biological Industries (Beit-Haemek, Israel). The purity of the sample is 
>98%. The stock powder protein was reconstituted with MilliQ water (Millipore, Billerica, 
MA), 10% glycerol and 1mM of dithiothreitol (DTT) to the stock concentration of 20 µM 
then stored at -80°C until use. Upon usage, this stock solution was then mixed with the 
nanopore buffer to obtain the final concentration without any further additives. The protein 
concentration inside the nanopore chamber ranged from 0.5-100 nM.  




by PCR. The DNA was separated on 0.7% agarose TAE gel, excised and extracted from 
the gel using the PCR cleanup kit (Promega). The DNA was further purified via ethanol 
precipitation, aliquoted at 0.1 pmol per tube and dried using the speedvac. It was stored at 
-20 °C. Prior to use, it was rehydrated in 10 microliter milliQ water and incubated at 37 °C 
for 1 hour at 300 rpm. 
Nanopore electrical sensing. Prior to the experiment, each NPs were treated with 
boiled piranha solution (70%H2SO4: 30%H2O2) to remove organic residues and make the 
NP interior walls hydrophilic, followed by intensive washing in MilliQ water. Upon the 
experiment, the nanochips were assembled in a custom-built Teflon cell and PDMS glued 
to prevent current leakage. Reservoirs on each side of the membrane are filled with a 
nanopore buffer containing 1 M KCl, 50 mM phosphate buffer, and 5 mM EDTA at 
different pH, as indicated. All buffers were filtered using a 0.02-µm syringe filter and 
degassed in vacuum right before use, and the pH of the buffer was verified immediately 
before the experiment. All experiments were performed inside a dark Faraday cage at 
constant temperature (22.0 ± 0.5°C). Two Ag wires were electroplated to form AgCl 
electrodes for both chambers, which connected to an Axon 200B amplifier (Molecular 
Devices) that applied a voltage clamp as specified across the membrane. The ionic current 
flowing through the pore was measured, low pass filtered at 100 KHz and analyzed using 
a custom LabView (National Instruments) code, which saved each and every current 
blockade event over time. The translocation events were analyzed and the ion current 
amplitude ∆G (the difference in the conductivities between the blocked and open pore) and 




Nanopore verification. In order to verify that a drilled chip can be used for 
nanopore measurements, an I-V curve is generated at the beginning of the experiment, in 
which the current is measured as a function of ramped voltage. Linearity between current 
and voltage in both negative and positive bias is verified. The pore’s thickness and diameter 
are verified using the open pore’s conductivity as well as the DNA translocation 
measurement, and confirmed with the electron micrograph of the pore obtained after 
drilling. For the full protocol and calculation, see SI.  
Reduction and digestion experiment. Reduction experiment was performed by 
addition of TCEP, which was diluted in water and neutralized by addition of concentrated 
KOH solution. For the plasmin digestion experiment, lyopolized plasmin powder is 
purchased from Sigma (Missouri, USA), reconstituted in water to the stock concentration 
of 0.1 µg µl-1 and then stored at -80°C until use. Upon usage, the stock solution was 
introduced directly into the nanopore chamber to the final concentration of 10 nM. 
Data collection. The electrical current across the nanopore was collected using the 
National Instrument A/D data acquisition boards via custom LabView Software at 250 kHz 
and low-pass filtered at 100 kHz.  
Data analysis and statistics. To compare across multiple voltage bias, the event 
amplitude is reported as a change in conductivity from the open pore current, defined by 
current normalized by bias. The absolute change in open pore current is used instead of 
fractional block level to be able to compare data across multiple pores which have varying 
diameters and thicknesses, hence different open pore currents. The translocation event is 




there for at least 16 µs, and then spontaneously returned to the open pore current. The time 
between the starting and ending point is defined as the translocation dwell time. The 
average event amplitude is the all-point average change in open pore current during the 
dwell time. The dwell time histograms were characterized by tail-fitting the data using 
exponential functions to reduce the effect of extremely fast events close to the temporal 
resolution of our amplifier. The event extraction and analysis are done in MATLAB and 
Igor Pro, respectively. 
3. Results and Discussion 
3.1 VEGF monomer/dimer population identification 
We chose VEGF as a model protein due to its clinical importance on the one hand, 
and due to its interesting and well-characterized structure, on the other hand. Purified 
recombinant VEGF165 was analyzed using locally thinned silicon-nitride (SiNx) 
membranes with a thickness of 12 nm to improve the spatial resolution of the 
detection25,32,37. Furthermore, the pore used were ~5.5 nm in diameter, slightly larger than 
the VEGF’s diameter (4.12 nm and 5.20 nm for VEGF monomer and dimer, respectively, 
estimated by their hydrodynamic radii, as shown in the Supporting Information file). The 
pore’s geometry was confirmed by conductance measurement as described in the SI. In the 
pore size range dprotein/dpore > 0.8 further enhancing the interactions between the mobile 
molecule and the pore’s wall25,38. Notably, we have carefully chosen the applied voltage 
and pH values in order to shift the mean translocation time much above the minimum 
resolution of our system (~10 µs) hence permitting the detection of VEGF translocations. 




collisions, we measured the characteristic dwell-time of VEGF ion current blockade events 
at pH 7.2 as a function of applied voltage. Our results (Figure SI 5) show that as the voltage 
amplitude increases from 300 - 700 mV, the mean residence time (obtained from tail-fitting 
the dwell time histogram with the exponential functions) decreases from 391 ± 55 µs to 56 
±4 µs. Notably, if the observed events were due to protein collisions, increasing voltage 
should result in longer dwell time39,40. 
Typical translocation events from a 20 nM VEGF solution at pH 7.6 are displayed 
in Figure 9a (V = +500 mV). Additional events are showed in Figure SI 6. This solution 
pH was chosen because VEGF isoelectric point is ≈ 7.4541, and thus, under a positive 
applied bias the protein would translocate from the cis to the trans chamber. Approximately 
85% of the events (Ntotal = 228) exhibited a single current event amplitude level (defined 
by the change in the pore conductance before and during the translocation event), which 
could be further classified into three groups or translocation populations according to their 
average event amplitudes (figure 9b, displayed in different colors). When fit by Gaussian 
functions, the three groups possessed a mean ± standard deviation of -1.1 ± 0.52 nS (Group 
A, marked in orange, NA= 86); -3.7 ± 1.4 nS (Group B, marked in red, NB = 79) and -6.2 ± 
1.4 nS (Group C, marked in blue, NC = 30) (Figure 9b). Additionally, about 15% of the 
translocation events contained multiple blockage levels within one event.  
Immediately following this experiment, and using the same NP, the VEGF solution 
was treated with 0.5 mM tris(2-carboxyethyl)phosphine (TCEP) to chemically reduce the 
protein’s disulfide bonds. As shown in Figures 9c and d, the subsequent NP measurements 







Figure 9. Reduction of VEGF results in altered oligomeric states, reflected by different ssNP 
translocation populations’ distribution. (a,b) representative translocation events of 20 nM 
VEGF and the amplitude histogram (V=+500 mV). Orange, red, and blue represent groups A, B 
and C, respectively. The grey bar represents segmented levels from multi-level events. The scatter 
plot of the event histogram vs event amplitude is shown in the SI. (c,d) 15 minutes after adding 
0.5 mM of TCEP directly into the NP chamber with 20 nM VEGF. This experiment was done in 
the same NP as of (a,b). (e) SDS gel electrophoretic image of VEGF before and after reduction (a 
full-length gel shown in Figure SI1). Cartoons illustrate native dimeric VEGF (left) and 




observed in the absence of the reducing agent (Figures 9a-b) converged into a single 
group (92%) at -1.6 ± 0.47 nS (Ntotal = 125, Figures 9c-d) labeled in orange color. This 
group had similar amplitude and dwell time as the translocation events of group A, prior to 
TCEP treatment. 
The convergence of the three translocation populations into a single, lower-
amplitude, translocation population after TCEP treatment led us to speculate that these 
three distinctive groups, observed at pH 7.6, represent the VEGF monomer as well as the 
dimers and trimers connected via disulfide bonds. Upon TCEP reduction, the majority of 
the higher order structures are reduced to give the monomeric form, which remains intact 
due to additional intra-hydrophobic interactions16,42. In support of this conclusion, a VEGF 
solution was treated with TCEP and analyzed by sodium dodecyl sulfate polyacrylamide 
(SDS-PAGE) gel electrophoresis. The bands corresponding to the dimers and trimers of 
VEGF were no longer present and only the single band of the VEGF monomer was 
observed (Figure 9e). 
3.2 VEGF population dependence on pH and concentration 
When the pH of the VEGF solution was lowered to 7.2, below its pI, VEGF 
translocation behavior significantly changed. First, as expected, applying a positive bias no 
longer afforded protein translocation as the protein is positively charged, while applying a 
negative bias (i.e., V = -500 mV) resulted in translocations (Figure 10a). Second, the VEGF 
translocation events (Ntotal = 214) were characterized by only two amplitude populations, 
A (55%) and B (12%) (Figure 10b). At the same time, we observed an increase in the 





 (33%, as opposed to 15% in the pH 7.6 case, shown as a grey histogram in figure 
10b). Further analysis of these multi-level events revealed that many of the multiple 
blockage levels showed a discernable pattern of B and A transition (28%, Figure 10a third 
event, additional events are provided in the SI Figure SI 4). As before, reduction of the 
solution using TCEP shifted the population towards single level A events (-1.9 ± 0.70 nS, 
 
 
Figure 10. VEGF translocation at pH 7.2. (a,b) representative translocation events of 20 nM 
VEGF pH 7.2 (V=-500 mV) and its amplitude histogram. Orange and red represent group A and 
B respectively. The grey color represents segmented levels from multi-level events. (c,d) 20 
minutes after adding 0.5 mM of TCEP. Cartoons illustrate the interpretation that the monomer 
exist in the solution, and are reduced after adding TCEP. Cartoons show monomeric and dimeric 








71%, Ntotal=360), consistent with monomeric VEGF translocations (Figures 10c-d).  
Multi-level protein translocation have been previously observed and rationalized as 
protein trapping or rotating inside the NP35,43, resulting in a fluctuation of the current.  In 
our experimental design, we selected the pore’s geometry to be smaller than the predicted 
largest dimension of monomeric VEGF (see figure SI 8 for VEGF’s crystal structure) to 
restrict rotational movement. Furthermore, among the multilevel translocation events, 81% 
of them showed explicitly bi-level transition from B to A (57 out of 70 events). This 
predominantly asymmetrical pattern indicates that the protein may not freely rotate in the 
NP (leading to a random pattern). Other researchers have proposed that the multilevel 
translocations originate from a complete unfolding and linearization of the protein24,44–48. 
Our theoretical calculations showed that the expected blocked level of a completely 
linearized peptide will be undetectable as its signal will be below the noise threshold (~0.2 
nS, see SI) and not similar to the current in level A. Hence, a plausible explanation is that, 
 
Figure 11. NP sensing detects changes in the steady state equilibrium of VEGF oligomeric 
states. Percentage of group A translocation events as well as group B and B/A translocation events. 
The experiments were done in ~5-6.5 nm pore at pH 7.2 (V = -500 mV). The data trend is guided 




rather than complete unfolding, the B to A transition originates from protein shearing or 
partial dissociation of the VEGF dimer to its monomeric form. We cannot rule out either 
scenario, but it is more likely to be predominantly protein shearing since, in most 
translocations, level B is immediately followed by level A without a current jump to the 
open pore level. In contrast, if partial dissociation events were predominant, we should 
have observed B to A events, where a small excursion of the current to the open pore level 
is followed by an A event, and this is not the case. Furthermore, we observed that this 
multistep translocation behavior is dependent on the pH (i.e. more fraction of B/A events 
observed at pH 7.2 as oppose to at pH 7.6). This is in agreement with the finding that 
disulfide bond stability is also pH dependent49. 
To further investigate the dependencies of VEGF dimer and higher-order oligomer 
translocations, the concentration of VEGF was varied from 0.2 nM to 100 nM, which 
covers the physiological relevant concentration range of VEGF10. As the concentration of 
the protein increases, the ratio of monomer structures shifted towards the dimeric state (i.e., 
a greater percentage of B and multi-level B/A translocations as opposed to A only 
translocations). As shown in Figure 11, the percentage of population A translocations 
decreased from 94% at 0.2 nM to 10% at 100 nM, while the percentages of level B and 




3.3 VEGF’s domain characterization 
As mentioned in the introduction, the VEGF receptor recognition (VEGF1-110) and 
the heparin binding (VEGF111-165) domains are connected by a linker sensitive to cleavage 
by plasmin. Plasmin plays a critical role in the VEGF signaling pathway by releasing the 
VEGF receptor recognition domain from the heparin binding domain in extracellular 
matrix, thereby promoting its binding to the VEGF receptor17. To study this biochemical 
 
Figure 12. Plasmin-catalyst VEGF cleavage experiment. Cartoons represent the VEGF in 
native state (left panel), and upon reduction with plasmin which results in positively charged 
VEGF111-165 domain (middle panel) and negatively charged VEGF1-110 domain (right panel). (a,b) 
representative events and the amplitude histogram of 20 nM VEGF at pH 7.2. Orange and red 
represent group A and B, respectively. (c) The dwell time histogram of group A events, tail fit by 
an exponential function to obtain the characteristic dwell time. (d,e) Translocation events after 15 
min of adding plasmin. (f) The dwell time histogram of group A1 events.  (g,h) The translocation 





reaction at the single molecule level, plasmin (10 nM) was added to a solution of VEGF 
(20 nM) at pH 7.2, and the translocation events were monitored (Figure 12). The 
translocation profile shifted from three groups (Figure 12a-c) to a single-level amplitude 
population at -0.94 ± 0.43 nS (87%, Ntotal=83, Figures 12d-f), which we denoted group A1. 
These translocation events corresponded to the translocation of the positively charged 
VEGF111-165 domain. When the applied bias was switched to a positive bias, single-level 
translocations of the negatively charged VEGF1-110 domain were predominantly measured 
with an amplitude of -1.4 ± 0.70 nS (85%, Ntotal = 91, Figures 12g-i), marked as group A2. 
Importantly, there were no recorded events that correspond to the translocation of plasmin 
itself. As expected, the 83-kDa plasmin did not translocate with either bias since the pore 
diameter (4.5 nm) was too small to accommodate this large protease (~9 nm, from pdb file 
ID 4DUU, see Figure SI 8 – SI 9).  
Next, we characterized the enzymatic catalysis rate of VEGF by plasmin by 
measuring the events’ rate at different time points after addition of plasmin (Figure 13). 
The reaction was probed under a negative bias. Prior to the addition of plasmin (t < 0), 57% 
of the events were contained in group A. Upon addition of plasmin, the percentage of the 
A and A1 events, corresponding to the positively charged positively charged VEGF111-165 
domain, increased to 87% after 10 min (orange line) and remained unchanged. In contrast, 
the percentage of group B and B/A events decreased from 28% to less than 10% after 10 
min (red line). When plasmin cleaved the VEGF dimer, the positively charged VEGF111-
165 domain was detached from the negatively charged VEGF1-110 receptor recognition 




through the pore. This results in a reduction in the number of group B and B/A events. We 
further determined that the half-life of VEGF1-165, which corresponds to group B blockage, 
is in a timescale of 10 min under our experimental condition, (20 nM VEGF, 10 nM 
plasmin). The calculated rate constant of the reaction in these conditions is 1.6 · 105 M−1s−1, 
which is a typical rate constant for a protease reaction (see SI for detailed calculation and 
summarized data). 
 
Under a positive bias, the translocations from the plasmin experiment arose from 
passage of the negatively charged VEGF1-110 receptor recognition domain A2. Interestingly, 
the population amplitude resembled the translocation of the monomeric VEGF (group A, 
figure 12b). This result suggests that the blockage level of monomeric VEGF is dominated 
by the blockage level of its VEGF1-110 domain. This interpretation is also consistent with 
the results from the TCEP reduction experiments where the disulfide bonds between dimers 
 
Figure 13. Kinetics of plasmin-catalyzed VEGF dissociation probed by NP. At t=0 min, 10 
nM of plasmin was added into the NP chamber containing 20 nM VEGF and then the 
translocation behaviour was tracked as a function of time (V= -500 mV). The ~4.5 nm NP was 




were reduced, however, VEGF1-110’s secondary structure remained intact due to the 
hydrophobic interactions between the four chains18.  
Although the presence of the VEGF111-165 domain did not contribute to the blockage 
level, it did alter the overall charge and NP dwell time of the protein. The dwell times were 
168 ± 49 µs, 50 ± 5 µs to 166 ± 31 µs, for VEGF1-165, VEGF1-110, and VEGF111-165 
respectively (figure 12c,f,i). The full monomeric VEGF translocated slower than the 
cleaved VEGF111-165 domain because the overall charge was closer to zero. These results 
show that the NP can be used to differentiate the alternative splicing isomeric state of 
VEGF; VEGF-165 and VEGF-121 simply by switching bias.  
4. Conclusion 
Choosing VEGF as a model protein, we were able explore and elucidate the up-to-
date hidden potential in NP probing of proteins. Our analysis demonstrates that careful 
analysis of the translocation patterns embeds significantly important information that can 
be harnessed to better characterize and quantify structural determinants of any given 
protein in solution. By manipulating the assay conditions, changing the pH of the analyte, 
using either reducing or non-reducing conditions and alternating the electrical bias, we 
were able to monitor changes in the native oligomeric states of VEGF. The NP 
translocation results obtained at pH 7.6, above the pI of VEGF, were expected and matched 
the observed oligomeric states of VEGF on SDS-PAGE under reducing and non-reducing 
conditions. However, our results, which were obtained at pH 7.2, below the pI of VEGF, 
were surprising and emphasized how slight pH change can affect the structure of the 




the relative amounts of monomer to higher oligomeric states in real time. Hence, we 
suggest that NP sensing can be used to complement the structural information obtained by 
classical methods, such as NMR, analytical ultracentrifugation and solution scattering.  
VEGF has a well-established role in promoting angiogenesis and it is an important 
therapeutic target for cancer treatment. However, the exact roles of different VEGF 
isoforms, and particularly that of the predominant VEGF121 and VEGF165, are not entirely 
understood. This is mainly due to lack of isoform-specific antibodies to use in ELISA, the 
gold standard quantification method available nowadays. By carefully analyzing the ssNP 
translocation patterns of VEGF domains cleaved by plasmin, we developed a method to 
specifically identify and quantify each isoform. Experiments are currently ongoing to study 
other biologically-significant cytokines using our approach. Specifically, to determine if 
different proteins exhibit unique translocation signature/profile as a function of pH, applied 
voltage and polarity. A combination of nanopore signature with antibody or aptamer might 
be useful in separating a target protein from solution mixture. In the future, this method 
can be utilized in the clinic to analyze patient samples and better assess each isoform-
specific potential to use as predicative biomarkers for anti-angiogenic therapy.  
5. Supporting Information 
5.1 Full-length gel electrophoresis image of VEGF before and after reduction with 
TCEP  
Figure SI 1 shows a denaturing gel (SDS-PAGE) of the recombinant VEGF used 
in this experiment. The stock solution of 20 µM VEGF was diluted to final concentration 




TCEP was added into the solution to obtain the final concentration of 10 mM and allowed 
the disulfide reaction to occur for 15 min. Both solutions were then mixed with 5x sample 
buffer containing 10% SDS, 20% glycerol, and small trace of bromophenolblue and boiled 
for 5 min. 
The gel electrophoresis was performed using 4-20% TGX precast gel (Biorad, 
USA) with Tris/Glycine/SDS running buffer in electrophoresis gel apparatus (Biorad, 
USA). The voltage was set at 200 V and run for 30 min. The gel was then stained using a 
















Figure SI 1. SDS-PAGE of VEGF, before and after interacting with 
TCEP. Silver stain. Lane1: 1 kb DNA Ladder (New England Biolabs, USA). 
Lane 2: 0.5 ug of VEGF without TCEP. Lane 3: 0.5 ug of VEGF with 




5.2 Evidences of VEGF dimer and monomer in bulk solution: Mass spectroscopy 
result of VEGF 
Matrix assisted laser desorption ionization-time of flight mass spectrometry 
(MALDI-TOF MS) was performed to detect the presence of monomer and dimer of VEGF 
at pH 6.8 and 8.0, as shown in figure SI 2. Roughly, 1 µg of VEGF was diluted into 1 ul of 
50 mM phosphate buffer at pH 6.8 and 8.0 and was equilibrated for 15 min (final 
concentration, 50 uM). The VEGF solution was then deposited onto a HCCA/1% TFA 
solution on a target plate and quickly dried using heating gun. The sample was then 
analyzed the mass spectra using MALDI-TOF MS technique (Bruker autoflex Speed, at 
10-50 kDa window). The mass spectra consistently showed a mixed population of 
monomer, at 19-kDa peak and dimer at 38-kDa peak. We also observed that the ratio 
between two peaks were not the same in two different pH. Although we realized that the 
ionization process might artificially introduce more monomer, this result provided a 




varied as a function of pH’s solution.  
5.3 Determination of a nanopore’s geometry 
We evaluate the pore’s geometry (thickness and diameter) by first using the 
measured parameters obtained from the fabrication process and later on confirmed with the 
conductance measurement. Initially, the film thickness was determined by the elipsometer. 
With a known etching rate, the locally thinned area thickness was calculated. After the 
nanopore was formed by mean of the transmission electron microscope (TEM), the electron 
micrograph of the pore was taken and used to measure the diameter of the pore. We 
anticipate that after the pore went through intensive cleaning with piranha solution, the 
final geometry might change, thus the conductance measurement was performed before the 
 
Figure SI 2. Representative MALDI-TOF-MS spectra of 5uM VEGF pre-equilibrated in 




protein translocation experiment. The dsDNA was translocated through a nanopore and the 
open pore current as well as the blocked current were measured. The two set of equations, 
which derived from a geometrical model of pore conductance, were used to fit the two 
unknowns (thickness and diameter)50.  
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And 








, 𝑑𝑒𝑓𝑓 = √𝑑𝑝2 − 𝑑𝑀
2    (eq.S2) 
Where, ∆𝐺 and 𝐺𝑜 are the event amplitude and open pore current respectively. 𝑙 is 
length of the pore, 𝑑𝑒𝑓𝑓 is the effective diameter of the pore when the pore diameter dp is 
partly occupied by the molecule diameter 𝑑𝑀. 𝜎 is the buffer solution conductivitiy (10.5 
nS nm-1 for 1M KCl, 25°C). Using this model, the pore we used in this study was found to 
have a thickness, 𝑙 = 12 nm and 𝑑𝑝 =6.0 nm. 
5.4 Translocation of VEGF in comparison with DNA 
As a control, and to ensure that the nanopore itself did not bias the translocation 
pattern of the VEGF, DNA translocation experiment was performed to verify the pore’s 
geometry and its performance. After VEGF translocation experiment, we washed the cis 
chamber with clear buffer and immediately measured the translocation of 5 kbps dsDNA. 
As expected, the dsDNA produced a single cluster of events (Figure SI 3b, right panel) 
with event amplitude of -1.5±0.3 nS (N = 616) and a characteristic dwell time of 75±15 µs, 






5.5 Estimation of the linearized peptide’s event amplitude 
If VEGF subjected to be unfolded and linearized, it would have a length of 85 nm 
(estimated by bond length of 165 amino acids) and approximate cross section 0.45 nm 51. 
Since unfolded peptide translocated as a linear chain, the relationship between the event 
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Figure SI 3. Comparison between VEGF and DNA translocation (a) The translocation 
behavior of VEGF. (b) scatter plot of VEGF translocation shows three distinctive populations 
(different color). (c) Amplitude histogram of VEGF translocation events. (d-f) The translocation 
of 5 kbps DNA was also performed for comparison. The experiment was done in the same 6.0 nm 




This equation gave an expected block current of a linearized peptide of 0.2 nS, 
which is smaller than the value obtained in the experiment by a factor of 10. Therefore, it 
is unlikely that VEGF is translocated through the nanopore as a fully linearized peptide 
under our experimental condition. 
5.6 Estimation of the hydrodynamic diameter of the VEGF protein. 
To determine the hydrodynamic diameter of the VEGF protein, 𝑑𝐻 , we first 
estimate the theoretical smallest size of the protein assuming that it is a closed-pack 
spherical particle according to Erickson’s formula52 
𝑑_min = 2𝑟𝑚𝑖𝑛 = 0.132𝑀
1
3       (eq.S4) 
for M in Dalton and dmin in nanometer.  Then assuming the shape correction factor of 1.2 
as VEGF is relatively spherical shape and experimentally determined by sedimentation 
analysis53, the hydrodynamic radius is 4.12 nm and 5.20 nm for VEGF monomer and dimer 
respectively.  
This value is in the same scale as when the hydrodynamic radius is calculated from 
crystal structure of VEGF (pdb file: 1vpf) using an algorithm named HYDROPRO54, which 




5.7 Continuous pore current during the VEGF translocation  
 
5.8 Voltage-dependent VEGF translocation 
In order to verify that most of the ion current blockade events correspond to protein 
translocation and not collisions, we measured the dwell-time histogram of VEGF under 
different voltages using the same nanopore. Briefly, VEGF was introduced into a 
nanopore chamber containing 1 M KCl, 50 mM phosphate buffer at pH 7.2 and 5 mM 
 
Figure SI 4. The pore current during VEGF translocation at pH 7.6. (a) Representative open 
pore current. While the apparent event capture rate is high (~0.03 molecule sec-1 nM-1), the pore 
subjected to long-timescale reduction in open pore current which we contribute to the non-specific 
adsorption of a protein onto the pore’s surface. For consistency, we discarded the data where the 
open pore current fluctuated (denoted as OFF in the graph). A typical time for data collection in 






EDTA such that the final concentration of the protein is 20 nM. The voltage bias was set 
at -300 mV on the trans (opposite) chamber to attract positively charged VEGF. After 10 
minutes of data collection, the voltage bias was changed to -500 mV, data was collected 
for another 10 minutes and same procedure was repeated at -700 mV. Figure SI 5 shows 
the result of this voltage-dependent experiment.  
As the absolute value of voltage increases from 300 to 700 mV, the mean 
residence time (obtained from fitting the dwell time histogram with the exponential 
functions) decreases from 391±55 µs to 56±4 µs. Notably, if the observed events were 
due to protein collisions, increasing voltage should result in longer dwell time39. This 
 
Figure SI 5. Dwell time histograms of the VEGF translocation at different voltage bias show 
a sharp decrease in the characteristic dwell time as a function of voltage. (a- c) The histograms are 
tail-fitted with the exponential functions (~exp(-t/TD) function to determine the characteristic 
dwell time. (d) The characteristic dwell time as a function of applied voltage. The three data set 




experiment thus negates this possibility, supporting the hypothesis that the observed 
events likely result from the translocation of VEGF.  
5.9 Example event traces of VEGF at pH 7.6 before and after TCEP  
Here we showed additional translocation events from VEGF at pH 7.6 before 
introducing TCEP.  
 
Figure SI 6. Additional events of VEGF before and after reduction (a) Example event traces 
of 20 nM VEGF at pH 7.6, (b) after introducing 0.5 mM of TCEP. (c) The scatter plot of VEGF 
translocation at pH 7.6. There are 3 distinctive group of events classified by their amplitude. 
Orange, red, and blue represent group A, B and C respectively. The grey dots represent segmented 
levels from multi-level events. For instant, a multi-level with 2 sublevels contributes to 2 grey 
















































































5.10 Example event traces of VEGF at pH 7.2 before and after TCEP 
Here we showed additional translocation events from VEGF at pH 7.2 (figure SI 
7a). One can see that the event that exhibits multiple steps mostly in B to A transition 
pattern. Different level is clearly distinguished and larger than the noise floor. After 































































5.11 Crystal structure of proteins involved in the study  
 
5.12 Determining the turnover rate of plasmin-digested VEGF reaction using 
nanopore 
From figure 13 in the main chapter, we determined the VEGF turnover rate with 
plasmin to have a half-life of ~10 min. To obtain the reaction rate constant, we first 
assume that the rate-limiting step of the reaction is the first process, where VEGF165 is 
cleaved into VEGF1-110 and VEGF111-165 ; 
 
Figure SI 8. Crystal structures of the protein used in this experiment. (a) VEGF receptor 
recognition (body) domain. A monomer is shown in red and another monomer is shown in blue. 
Three disulfide bonds which stabilize the internal structure by forming cysteine knots are indicated 
by red and blue arrows for each monomer. Two disulfide bonds that involved in dimerization are 
indicated by green arrows. The residue numbers are labelled. The crystal structure is obtained 
from pdb file 2vpf and rendered in VMD. (b) Heparin binding (tail) domain consists of four 
disulfide bonds that stabilize the internal structures, indicated by blue arrows. The crystal structure 
is obtained from pdb file 1vph. (c) Human plasmin (ogen) used for cleaving VEGF body and tail 
domains for size comparison. The crystal structure is obtained from pdb file 4ddu and rendered in 
VMD. 
Intramolecular  disulfide bond within a VEGF monomer
Intermolecular disulfide bond between VEGF dimer





VEGF165 + Plasmin → VEGF1-110 + VEGF111-165+ Plasmin 
This sequence follows the first order kinetics as shown by Vempati et al. 55, 
𝑑[𝑉𝐸𝐺𝐹165]
𝑑𝑡
=  −𝑘𝑝[𝑝𝑙𝑎𝑠𝑚𝑖𝑛][𝑉𝐸𝐺𝐹165] 








Under our experimental condition (10 nM plasmin), the reaction constant is 
1.6·105 M−1s−1. This kinetic parameter is representative of high end of extracellular 
matrix protease reactions and two order of magnitude higher than the experimental value 
in bulk 5·103 M−1s−1 (see table below). We expect that our rate constant will be higher 
since our sample lags of glycosylation, hence the cleavage site is more exposed to 
plasmin digest. 
 
Table SI 1. The reported reaction rate constants of various protease systems 
Substrate Protease Kp  temperature Ref. 
collagen MMP-1 900∙103 M−1s−1 30°C 56 
Type I collagen  collagenase  120∙103 M−1s−1 37°C 57 
Glycosylated VEGF Plasmin 0.6 ∙103 M−1s−1 25°C 58 












Figure SI 9. Representative continuous current traces of the pore during the plasmin cleavage experiment. The continuous current 
was collected at 25 kHz and filtered using moving average (bin of 3) for visualization. After each experiment was done, the pore was 
thoroughly washed with nanopore buffer 3 times and make sure that there was no event observed before introducing a new analyst. All 
data are collected in the same pore consecutively (diameter 4.5 nm, thickness 7 nm, pH 7.2) 






5.14 The raw experimental result of VEGF concentration dependency 
Table SI 2. The experimental result of VEGF translocation at different concentration which is used to generate the figure 4 in 














A B C A/B else %A 
%B + 
B/A 
1 0.2 7.2 4 7 500 54 38 16 0 0 0 70 30 
2 10 7.2 6 20 500 153 115 10 16 5 7 75 10 
3 20 7.2 4.5 12 500 73 33 20 2 11 7 45 42 
4 20 7.2 4 12 500 80 39 12 0 22 7 49 43 
5 20 7.2 4 12 500 104 43 24 9 5 23 41 28 
6 40 7.2 6 12 500 130 50 42 7 22 9 38 49 
7 40 7.2 4 12 500 130 54 35 6 22 13 42 44 
8 50 7.2 6.5 12 500 103 14 48 21 6 14 14 52 
9 100 7.2 6.5 12 500 212 21 88 7 37 59 10 59 
10 100 7.2 4.2 7 400 246 16 85 0 118 27 7 83 
11 100 7.2 4.2 7 400 168 17 62 0 61 28 10 73 
12 5 7.2 6.3 12 300 42 37 0 0 5 0 88 12 




5.15 Additional data sets
 
Figure SI 10. Additional data set for VEGF translocation experiment at pH 7.6 (a,b) 
and with addition of TCEP (d,e). The experiment was done in 6.5 nm diameter, 12 nm 






Figure SI 11. Additional data set for VEGF translocation experiment at pH 7.2 (a,b) and 
with the addition of  TCEP (c,d). The experiment was done in 6.5 nm diameter, 12 nm 






Figure SI 12. An additional experiment for plasmin cleavage reaction. (a) The scatter plot of 
the amplitude vs dwell time of the VEGF translocation events at pH 7.2 probed at -500 mV. (b) 
The event amplitude histogram and (c) dwell time histogram of VEGF translocation events. (d-f) 
The scatter plot, amplitude histogram and dwell time histogram of VEGF, 15 min after addition of 
plasmin. The translocation events were probed under the negative bias. (g-i) The translocation 
events after addition of plasmin, probed under the positive bias (+500 mV). The entire set of the 




5.16 Modeling the translocation dwell time of VEGF monomer and dimer using drift-
diffusion model. 
A general problem associated with protein translocation study inside nanopore is 
that the mean translocation time of the protein is typically faster than the temporal 
resolution of the protein. 1D-drift diffusion model is normally used to describe the 
translocation dwell time of the protein and DNA travelling through the nanopore, resulting 








4𝐷𝑡      (eq.S15) 
Where D is the diffusion coefficient, v is the protein’s drift velocity. Figure SI 13 
shows the translocation event of 20 nM VEGF at pH 7.6 using a pore with 5.5 nm in 
diameter, 12 nm thickness and +500 mV pore’s bias. The dwell time histogram of all events 
shows an exponential decay shape with a mean dwell time of 160 µs (figure SI 13b). 
However, once the population are separated into two groups (figure SI 13c and d), the dwell 
time histogram could be fit with the drift-diffusion model, yielding the diffusion coefficient 
of 3.35  10-13 m2 s-1 and the drift velocity of 1.30  10-4 m s-1 for monomer (yellow) and 
1.23  10-12 m2 s-1 and 4.26  10-4 m s-1 for dimer (red).  
We asked if we were missing any VEGF translocation events due to the temporal 
resolution limit of our amplifier or not. Using the experimental fitting, we reconstructed 
the dwell time probability distribution function and determine the percentage of the events 
that are shorter than 20 us (10 us temporal resolution) based on the area under the curve. 




roughly 42% of the dimer translocation. This calculation emphasizes the ability to slow 
down protein’s translocation dwell time based on controlling pH, voltage, and pore’s 
geometry, through modifying the protein’s diffusion coefficient and drift velocity.   
Finally, when comparing with the theoretical bulk diffusion coefficient of VEGF 
monomer and dimer, our observed value is roughly 3-order of magnitude lower (1.18  10-
10 m2 s-1 and 0.94  10-10 m2 s-1 for VEGF monomer and dimer, see calculation below). This 
is expected as the diffusion coefficient in nanopore is typically lower than that of in bulk 
due to confinement effect and interaction between protein and pore’s wall. When the 
geometrical confinement is taking into account,23 the diffusion coefficient is 5.4  10-13 m2 
s-1and 1.67 10-14 m2 s-1 for monomer and dimer, an order of magnitude lower than the 
experimental value. On the other hand, the observed drift velocity of both monomer and 
dimer is 5 times higher than the bulk value (2.6  10-5 m s-1 and 2.1  10-5 m s-1 for monomer 
and dimer, in 1 M KCl). Figure SI 13e shows the probability density function of monomer 
and dimer generated from the theoretical values. This calculation highlights that protein’s 
translocation inside the nanopore is a complex process that requires intensive further study 
before it could be used to predict the actual translocation dynamic of a protein inside the 
nanopore. The potential cause of deviation includes, but not limit to, (1) protein interaction 
with the pore’s wall, (2) protein-protein interactions. (3) protein’s asymmetrical shape and 
polarization of the protein during transport inside an electric field, (4) non-uniform voltage 
distribution across the pore’s thickness, (5) protein’s unfolding and shearing, (6) protein 







Figure SI 13. Fitting VEGF translocation population using drift-diffusion model. (a) A 
scatter plot of VEGF translocation events showing three populations. (b) When the dwell time 
of every events are plotted as a histogram, the distribution could be fit with the exponential decay 
with the characteristic dwell time of 160 ± 30 us. (c) When only the events that are classified as 
A (monomer) are plotted, the fit with the drift-diffusion model yields the observed diffusion 
coefficient of 3.35  10-13 m2 s-1 and the drift velocity of 1.30  10-4 m s-1. (d) When only the events 
that are classified as B (dimer) are plotted, the fit gives yields the observed diffusion coefficient 
of 1.23  10-12 m2 s-1 and the drift velocity of 4.26  10-4 m s-1. (e) the theoretical model shows the 
pdf of translocation time for monomer and dimer, together with the calculated values for both 





5.17 Determining the theoretical diffusion coefficient and drift velocity in confined 
pore 
First, we attempted to calculate the theoretical diffusion coefficient of VEGF 
monomer and dimer. The diffusion coefficient in liquid, 𝐷𝑜 , could be calculated using 




        (eq.S4) 
Where 𝑘𝑇 is the Boltzmann constant and absolute temperature respectively. 𝜂 is 
the viscosity of the media, 𝑟𝐻 is the hydrodynamic radius of the protein assuming that it 
has a spherical shape. The hydrodynamic radius of VEGF is determined to be 2.06 and 
2.60 for monomer and dimer respectively (see the previous SI section). The viscosity of 
the buffer is assumed to be that of water at 8.90  10-4 Pas. When substituting the 
parameters into equation S4, the bulk diffusion coefficient is 1.18  10-10 m2 s-1 and 0.94  
10-10 m2 s-1 for VEGF monomer and dimer respectively. However, the diffusion constant 
of protein travelling in constrained porous media is significantly lower than the value in 
bulk, which could be calculated by the empirical formula originally developed by Renkin 
[cite Wanunu, Stroeve 2014 and Renkin].  





[1 − 2.104 (
𝑟𝐻
𝑟𝑝










 ]  
  (eq.S16) 
Where 𝑟𝑝 is the pore’s radius. Using 2.75 nm value for the pore radius, a diffusion 
constant for monomer and dimer VEGF in the pore is 5.82  10-13 m2 s-1 and 1.66  10-14 m2 




On the other hand, the drift velocity, 𝜈, of the protein can be calculated by Stroke-
Einstein equation; 









      (eq.S17) 
Where 𝑄𝑒𝑓𝑓(𝑝𝐻) is the total charge of the molecule, which is a function of pH. To 
obtain the value of effective charge of a protein, we first calculate the theoretical charge 
𝑄∗(𝑝𝐻) based on the amino acid sequence [peptidecalculator.org], to obtain a charge of -
0.4e in monomer at pH 7.6 and -0.8e in dimer at the same pH. However, since the protein 
is in a strong electrolyte (1 M KCl, nanopore buffer), the electrostatic interaction is 
screened and the effective charge of the protein could be calculated by Debye-Hűckel-




𝑓(𝜅𝑟𝐻)      (eq.S8) 
Where 𝜅 is the inverse Debye’s length (which is 0.3 nm in 1 M KCl) and 𝑟𝐻 is the 
hydrodynamic radius of the protein. 𝑓(𝜅𝑟𝐻)  is the correction factor so called Henry’s 
function. At high ionic strength condition, a double layer is thin and 𝑓(𝜅𝑟𝐻) → 3/2 [cite: 
Swan and Furst, 2012]. As a result, the effect charge of the monomer and dimer of VEGF 
is -0.08e and -0.15e respectively. Finally, the drift velocity is determined to be 2.6  10-5 m 
















































6.6 2.7 5.4 0.51 1.03 9.9365E-05 1.3831E-04 2.5800E-09 4.1106E-09 1.537 2.448 397.089 3.54E+07 1.537 2.448     
6.7 2.3 4.6 0.44 0.88 8.4645E-05 1.1782E-04 2.1978E-09 3.5016E-09 1.309 2.086 66.968 1.18E+06 1.309 2.086     
6.8 2 4 0.38 0.76 7.3604E-05 1.0245E-04 1.9111E-09 3.0449E-09 1.138 1.814 17.283 9.05E+04 1.138 1.814 0.149 0.006 
6.9 1.6 3.2 0.31 0.61 5.8883E-05 8.1959E-05 1.5289E-09 2.4359E-09 0.911 1.451 2.737 2.84E+03 0.911 1.451     
7 1.3 2.6 0.25 0.50 4.7843E-05 6.6592E-05 1.2422E-09 1.9792E-09 0.740 1.179 0.660 2.03E+02 0.660 1.179 0.460 0.053 
7.1 1 2 0.19 0.38 3.6802E-05 5.1224E-05 9.5557E-10 1.5224E-09 0.569 0.907 0.151 1.38E+01 0.151 0.907     
7.2 0.7 1.4 0.13 0.27 2.5761E-05 3.5857E-05 6.6890E-10 1.0657E-09 0.398 0.635 3.13E-02 8.49E-01 3.13E-02 6.35E-01 6.04E-01 6.62E-02 
7.3 0.4 0.8 0.08 0.15 1.4721E-05 2.0490E-05 3.8223E-10 6.0897E-10 0.228 0.363 5.31E-03 4.27E-02 5.31E-03 4.27E-02     
7.4 0.1 0.2 0.02 0.04 3.6802E-06 5.1224E-06 9.5557E-11 1.5224E-10 0.057 0.091 3.94E-04 9.41E-04 3.94E-04 9.41E-04 4.92E-03 1.99E-03 
7.5 -0.1 -0.2 -0.02 -0.04 3.6802E-06 5.1224E-06 9.5557E-11 1.5224E-10 0.057 0.091 3.94E-04 9.41E-04 3.94E-04 9.41E-04     
7.6 -0.4 -0.8 -0.08 -0.15 1.4721E-05 2.0490E-05 3.8223E-10 6.0897E-10 0.228 0.363 5.31E-03 4.27E-02 5.31E-03 4.27E-02 3.23E-02 3.73E-03 
7.7 -0.6 -1.2 -0.11 -0.23 2.2081E-05 3.0735E-05 5.7334E-10 9.1346E-10 0.342 0.544 1.79E-02 3.24E-01 1.79E-02 3.24E-01     
7.8 -0.9 -1.8 -0.17 -0.34 3.3122E-05 4.6102E-05 8.6001E-10 1.3702E-09 0.512 0.816 0.090 5.51E+00 0.090 0.816 0.762 0.475 
7.9 -1.2 -2.4 -0.23 -0.46 4.4162E-05 6.1469E-05 1.1467E-09 1.8269E-09 0.683 1.088 0.406 8.35E+01 0.406 1.088     
8 -1.5 -3 -0.29 -0.57 5.5203E-05 7.6837E-05 1.4333E-09 2.2836E-09 0.854 1.360 1.712 1.18E+03 0.854 1.360 0.355 0.196 
8.1 -1.9 -3.8 -0.36 -0.72 6.9924E-05 9.7326E-05 1.8156E-09 2.8926E-09 1.081 1.723 10.952 3.83E+04 1.081 1.723     
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CHAPTER 3: REAL TIME IN VITRO DETECTION OF VASCULAR 
ENDOTHELIAL GROWTH FACTOR (VEGF) SECRETION USING A 
NANOPORE SENSOR 
1. Introduction 
Vascular endothelial growth factor (VEGF) is a known cancer biomarker and is 
involved in the vascularization of tumor tissue in multiple diseases such as ocular vascular 
disease1, cancer, and heart disease. It signals endothelial cell angiogenesis by binding to 
the VEGF receptor (VEGFR), triggering receptor dimerization and signaling cell survival 
permeability (NF-kB pathway), actin reorganization (MAPK), cell proliferation (Ras), and 
cytoskeleton rearrangement (FAK/Paxillin) pathways. In cancer cells, VEGF is up-
regulated by oncogene expression, growth factors and hypoxia.2 Down regulation of VEGF 
by siRNA transfection, increases cell apoptosis in vitro,3 and reduces the tumor size in 
vivo4 relative to the control group. It is concentrated in cancer tissue and cyst fluid.5 
Increased concentrations of VEGF mRNA correlate to the malignancy level of the cancer 
tumor.6 In fact, VEGF secretion accounts for 0.3-0.5% of the total secretome of multiple 
cancer cell lines, and as such is one of the most prevalent cytokines.7  
The detection of VEGF is critical to studying its biology as well as to use it as a 
diagnostic and prognostic in patient care. Current methods to detect and characterize VEGF 
include X-ray crystallography,8,9 NMR,10 antibody, and aptamers. Aptamers are DNA or 
RNA 3 dimensional folded structures compose of 20 – 30 nucleotides. Their function is 
similar to traditional antibodies, but offer several advantages including an economical cost 




chemical stability. The first detection of VEGF by an aptamer was demonstrated by 
Ruckman et al.,11 in 1998 and since then have been used in VEGF targeted therapies such 
as ocular vascular disease1 and cancer, protein detection and diagnostics, and protein 
purification. Due to this, VEGF has become one of the most popular targets for aptamer 
research. Pegaptanib (5’-CGGAAUCAGUGAAUGCUUAUACAUCCG-3’-3’-dT-5’) 
forms two loops that interact with the VEGF heparin binding domain with a Kd of 49 pM.
12 
Other nucleotide sequences were later discovered to have a strong binding affinity to 
various isoforms of VEGF. Hasegawa et.al., used the systematic evolution of ligands by 
exponential enrichment (SELEX) method to develop the DNA aptamer VEa5 (5’-
ATACCAGTCTATTCAATTGGGCCCGTCCGTATGGTGGGTGTGCTGGCCAGATA
GTATGTGCAATCA – 3’) that forms a double loop structure and recognizes a 
recombinant VEGF-165 with a Kd of 116 nM.
13 Nonoka et al., screened 8 DNA aptamers 
and found that V7t1 (5'-TGTGGGGGTGGACGGGCCGGGTAGA-3') shows a strong 
binding affinity to recombinant VEGF-121 and 165, possibly binding to its VEGFR 
recognition domain with a Kd of 1.4 nM.14 Nonoka et.al., also used in silico maturation 
and identified that 3R02 aptamer (5’-TGTGGGGGTGGACTGGGTGGGTACC-3’) binds 
to VEGF with a Kd of 300 pM.
15 
Our interest is in detecting VEGF from the biological milieu using a solid-state 
nanopore, a single-molecule technique capable of stochastic sensing of small copies of 
biomolecules at high resolution. Several research groups have previously utilized aptamers 
for protein detection (((e.g., maybe we need to list the proteins))) using protein16–18 and 




used, solid-state nanopores21 provide additional advantages of controllable sensing region 
geometry and high mechanical robustness. In this study, we report nanopore sensing of 
VEGF using a DNA aptamer, discrimination of differential VEGF secretion in three 
different cell lines, and detection of VEGF in real time from triple negative breast cancer 
MDA-MD-231 cells. 
2. Experimental Section 
Nanopore Chip Fabrication and Electrical Measurement  The solid-state 
nanopore chips were fabricated using an electron beam sculpturing technique 22,23. Briefly, 
a <1 0 0> silicon wafer was coated with SiO2 (500 nm) and low-stress LPCVD silicon 
nitride film. The silicon wafer was etched through with KOH solution, creating a 
freestanding SiNx membrane with a thickness of ~7-20 nm. The chip was further thinned 
down by creating a locally-thinned area by focus ion beam lithography technique. NPs 
were drilled on the SiNx membrane using a highly focused transmission electron 
microscope (JEOL 2010 FEG- TEM, Peabody, MA), to sputter the SiNx material away. A 
4-6 nm pore was formed within 1 minute of focusing the beam. Prior to the experiment, 
the NP chips were treated with piranha solution (70% H2SO4: 30% H2O2) to remove 
potential organic contamination on the surface and enhance the hydrophilicity of the pore’s 
wall, rinsed with DI water for three times. The chip was then placed onto the custom-build 
NP chamber made of Teflon plastic and sealed using the fast-curing polydimethylsiloxane 
(PDMS) glue (Ecoflex 5, Smooth-On, Macungie, PA).  
Both channels were filled with a nanopore buffer containing 1 M KCl, 50 mM 




separately from Sigma-Aldrich, St. Louis, MO). All buffers were filtered using a 0.02-µm 
syringe filter (Whatman Anatop 10 syringe filter, Sigma-Aldrich St. Louis, MO) and 
degassed in vacuum right before each usage. All experiments were performed inside a dark 
Faraday cage at constant temperature (22.0 ± 0.5 °C). Two Ag wires were electroplated in 
2 M KCl solution to form AgCl electrodes. The electrodes were inserted into the electrode 
cavities providing access to the top and bottom set of the fluidic channels and connected to 
an Axon 200B amplifier (Molecular Devices, Sunnyvale, CA) as previously described.24 
The electrical current across the nanopore was low-pass filtered at 100 kHz Butterworth 
filter and sampled at 250 kHz. 
Custom LabVIEW software was used to detect the presence of the events due to 
analyte translocation. The starting point of the event occurred when the current dropped 
0.25 nA below the average open pore current and the event end point was defined when 
the current recovered to the open pore current value. The voltage clamp mode was used for 
all experiments. Event classification was performed off-line using a custom MatLab code 
(MathWorks, Natick, MA) to obtain the event characteristics. 
Determining the binding affinity between the aptamers and VEGF. All the 
single-stranded DNA and RNA aptamers were purchased from Integrated DNA 
Technologies (San Jose, CA). Bacteria-expressed VEGF were purchased from Biological 
Industries (Beit-Haemek, Israel) and the human-expressed VEGF were from Sigma-
Aldrich (St. Louis, MO). The aptamer was folded by heating up to 95°C for 5 min and 
gradually cool down at -2°C/min until reaching room temperature in 1X phosphate buffer 




The direct enzyme-linked oligosorbent assay (ELOSA) of aptamer and VEGF were 
performed by adsorbing 50 ng of VEGF onto the high protein binding 96-well plate in a 
50 µl of 1X PBS for overnight at 4°C. After washing two times by 200 µl of 1X PBS and 
0.05% Tween20 (PBST). The remaining protein-binding sites in the coated well were 
blocked by adding 200 µl of blocking buffer containing 1X of phosphate buffer saline and 
0.5% bovine serum albumin (Sigma-Aldrich, St. Louis, MO) for 4 hours at room 
temperature. The plate was washed twice with PBST and incubated with 100 µl of the 23.5 
µM of folded, biotinuated aptamers in blocking solution for half an hour at room 
temperature. Subsequently, the plate was washed twice with PBST and incubated with 
Steptavidin Poly-HRP (Pierce, ThermoFisher Scientific, Waltham, MA at 1:10,000 ratio) 
in blocking buffer for an hour at room temperature. After washing, the chemiluminescence 
readout was generated by using Supersignal ELISA Pico Chemiluminescence Substrate 
(ThermoFisher Scientific, Waltham, MA) according to the manufacturer’s protocol and the 
plate was immediately imaged by the plate reader. 
Determination of VEGF secretion level from human cell cultures. In cell culture 
assay, 10,000 cells of MDA-MD-231, MCF-7 and CaCo-2 (ATCC, Manassas, VA) were 
plated on the 24-well plates in cell culture media containing 1 ml of 1X Dulbecco′s 
Modified Eagle′s Medium (DMEM, ThermoFisher Scientific, Waltham, MA), 10% fetal 
bovine serum (FBS), 1% Penicillin/Streptomycin (P/S) antibiotics and a small trace of 
phenol red. The cells were incubated in 37°C, 5% CO2 incubator overnight. The cells were 
then washed by warm PBS and replaced with serum-free, phenol red-free 1X DMEM with 




and filtered with 50 kDa-cutoff ultra-centrifuge filter units (Amicon, MilliporeSigma, 
Burlington, MA) using the protocol recommended by the manufacturer. 50 µl of the culture 
media were determined the secreted VEGF concentration using ELOSA technique 
described earlier. The enzyme-linked immunosorbent assay (ELISA) was also performed 
in parallel to confirm the amount of VEGF using rabbit-host anti-VEGF polyclonal 
antibody (Abcam, Cambridge, UK using 1:2500 dilution ratio) serving as a primary 
antibody and a mouse-host antibody against a rabbit-host antibody conjugated with enzyme 
horseradish peroxidase (Cell Signaling Technology, Danvers, MA) as a secondary 
antibody (1:5000 dilution ratio). The readout was obtained using Supersignal ELISA Pico 
Chemiluminescence Substrate (ThermoFisher Scientific, Waltham, MA). The data points 
were collected in triplicate. The cell culture media were stored in -20°C freezer for future 
experiment.  
3. Results and Discussion 
3.1 Sensing VEGF aptamer binding using nanopore 
The VEGF monomer contains 165 amino acids and has a molecular weight of 18 
kDa. VEGF polymerizes via two disulfide bridges to form a dimer, trimer, or tetramer, 
which results in multiple bands in native gel-electrophoresis. Its monomer consists of two 
domains: the VEGF receptor recognition domain and the heparin binding domain, linked 
by a flexible linker containing a plasmin cleavage site. Disulfide bonds play a critical role 
in stabilizing the secondary and tertiary structures of VEGF. In the VEGF receptor 
recognition domain, three disulfide bridges connect two beta turns together, while four 




shown that solid-state nanopores of 4-7 nm in diameter and 10 nm in diameter can be used 
to study recombinant VEGF by obtaining the concentration and pH dependent dimerization 
and characterization of its domain structure without the use of chemical tags.25 
Nanopore experiments were performed using solid-state SiN nanopores with 
diameters of 6-8 nm and thickness of 7-12 nm, corresponding to the open pore current of 
25-40 nS at 1 M KCl. In a nanopore experiment, a large voltage potential is applied across 
a nanoscale hole to produce a strongly diverging electric field near the pore’s vicinity, 
resulting in electrophoretic forces that pull charged biopolymers through the pore. The 
control experiment to demonstrate a working nanopore and to estimate the nanopore 
diameter were performed using the 4 kbps NoLimits DNA in 1 M KCl, 50 mM phosphate 
buffered saline, 5 mM EDTA at pH 7.2 with the transmembrane potential held at + 500 
mV (see Figure SI 1). Next to a clean nanopore, the V7t1 ssDNA aptamer (1 nM) was 
added to the nanopore buffer and a positive transmembrane potential was applied. The 
folded aptamer events exhibit a deep amplitude of -1.41 ± 1.49 nS (N = 154, figure 14d-f) 
and moderately long dwell times (266 ± µs).  For comparison, experiments with the 
unfolded V7t1 under similar conditions resulted in short and shallow translocations that 
were difficult to resolve (See figure SI 14). Complexation of the VEGF to the V7t1 
aptamer (VEGF-to-DNA ratio 100:1, 1 nM) and application of a positive transmembrane 
potential, two populations were noted namely Group A and B (1:1.73), respectively (figure 
14a-c). Group A’s events were classified by a single blockage noted as level A-1: analysis 
of events reveals the average event amplitude (-2.04 ± 1.10 nS, N = 56) is similar to the 




events are attributed to the collision of VEGF/aptamer complex near the pore’s vicinity, 
potentially by the insertion of the aptamer as it favors the pore’s positive bias, but the entire 
complex wasn’t successfully translocated through the pore. Note that at the positive bias, 
the VEGF doesn’t translocate through the pore as its overall charge is positive. Whereas 
group B has a deeper mean event amplitude (-4.5 ± 1.5 nS, N = 97) and a longer dwell time 
compared to group A. Figure 14d-f shows the statistical analysis of the events’ average 
 
Figure 14 Scatter plots and event amplitude histogram aptamer and aptamer/VEGF 
complex. (a-c) 1 nM of folded V7t1 aptamer (d-f) 1 nM of folded V7t1 aptamer with an addition 





dwell time and event amplitude for both group A and B, and the two groups were clearly 
distinguishable by their average dwell time and event amplitude. 
 
 
Figure 15. Translocation Signature of VEGF/aptamer complex through solid state 
nanopore. (a) Two representative events from Group B1 and B2, respectively. (b) All-point 
histogram of the current trace from every event reveals the most common sublevel at -1.5 ± 
0.60 nS (corresponds to group A blocking level), -2.9 ± 1.73 nS and -6.6 ± 1.78 nS 
(corresponds to group B-1 and B-2 levels, respectively). (c) of Scatter plots and event 
amplitude histogram of (a-b) 100 pM of 4kbps DNA translocation (c-d) 1 nM of unfolded 
V7t1 aptamer (e-f) 1 nM of folded V7t1 aptamer (g-h) 1 nM of folded V7t1 aptamer with an 
addition of 100 nM VEGF. All experiments were done in a same pore with diameter of 6 nm 




3.2 Subevent analysis of the VEGF/aptamer complex 
Upon closer examination of the Group B translocations, the events can be further 
classified based on their pattern namely B1 and B2, respectively. Figure 15a shows a typical 
Group B1 and B2 events with labelled parameters. Group B1’s events show distinctive two 
consecutive sublevels namely level B1-1 and level B1-2: Level B1-1 features a transient 
single current level, follow by level B1-2 features a highly-fluctuated deep current level 
whereas group B2’s events have dominantly one deep blockage level, determined visually. 
The two sublevels were clearly identified when all-point histogram of the current traces 
were plotted (figure 15b). After de-noising, the current traces using wavelet transform, the 
level B1-1 and B1-2 were determined using thresholding methods (see SI for detailed 
algorithm). The block level of group B2 has the same amplitude as level B1-2, hence this 
level was assigned as B2-2. Surprisingly, the algorithm was able to detect a presence of 
very short dwell-time level B2-1 which the amplitudes matches those of level B1-1. The 
scatterplot of the average sublevel amplitude and dwell-time of both group B1 and B2were 
plotted in figure 15c. The current histogram and the dwell time histograms of each level 
are shown in the SI. The above finding supports that Group B1 and B2 have the same 
underlying molecular mechanism, hence the two groups will be combined in the future 
discussion. 
Interestingly, level B-1 (at -3.6 ± 0.27 nS) blocks slightly deeper than the level A-
1 and that of naked aptamer (figure 15c, and figure SI 15 in comparison with figure 15d). 
This observation suggests that the level B-1 is potentially a blocking of naked V7t1 aptamer 




heparin binding domain. On the other hand, level B-2 (at -7.3 ± 0.73 nS) is a due to a V7t1 
aptamer (contribute to -2.04 nS) together with the entire VEGF occupying the sensing 
region. For reference, the translocations of dimeric VEGF at pH 7.2 under the opposite bias 
(negative bias) have an average event amplitude of -4.5 ± 1.8 nS and dwell time of ~100 
µs (see figure SI 16).25 Exception long dwell time of level B-2 (3.5 104 ± 2.1104 µs, see 
 
Figure 16 VEGF level determined by ELOSA method. (a) Bind affinity between V7t1 aptamer 
and bacteria-expressed VEGF, (b) V7t1 and human cell-expressed VEGF, (c) 3R02 aptamer and 
human cell-expressed VEGF, (d) Pegaptanib aptamer and human cell-expressed VEGF. (e) 
VEGF secreted level by MDA-MB-231, MCF-7 and CaCo2 determine by Pegaptanib aptamer. 




figure SI 15) comparing with naked VEGF is attributed to the net positively charge of 
VEGF, hence it is struggled to translocate against the electric field and requires a help of 
densely negatively charged aptamers. Finally, there is no correlation between the dwell 
time of level B-1 and the dwell time of level B-2 (see figure SI 17), implying that the two 
levels occur independently and the aptamer/VEGF complex doesn’t translocate smoothly 
through the nanopore. The proposed molecular mechanism of aptamer/VEGF complex in 
a solid-state nanopore is illustrated in figure 15d. 
3.3 Screening VEGF aptamer binding to human-expressed VEGF 
To examine the versatility of this sensing strategy to detect the natural VEGF 
secreted from human cells, we revisited the conventional enzyme-linked immunosorbent 
assay (ELISA). The V7t1 aptamer exhibited binding affinity to bacterial expressed VEGF 
on the solid phase, however, when the human expressed VEGF (in HUVEC) was used, the 
binding curve showed biphasic behavior that exhibited high binding at the concentration 
less than 10 nM (figure 16a). We suspected that the non-specific binding at low 
concentration originates from lower binding affinity of V7t1 towards glycosylated version 
of human expressed VEGF. We further expanded our aptamer library to the 3R02 DNA 
aptamer26 and Pegaptanib RNA aptamer1. Both aptamer showed monophasic binding 
affinity with human expressed VEGF (figure 16c-d).  
3.4 Detection of VEGF using aptamer via nanopore from culture media 
Cell culture media contains hundreds of proteins, metabolites, and other 
biomolecules that potentially interfere with the nanopore detection by creating fault 




interference by using serum-free, phenol-free media and pre-filtered the cell culture media 
using high molecular weight cutoff filter. The result showed that the nanopore sensor can 
withstand a filtered serum-free media while was immediately blocked in a media 
containing 10% FBS (see SI). A 1 ul of MDA-MD-231 cell culture media containing 
secreted VEGF determined by ELOSA technique (figure 16e) was spiked into 40 µl of 
nanopore buffer containing 1 M KCl, 50 mM phosphate buffer and 5 mM EDTA at pH 7.2. 
Figure 17e-f shows the analysis of the events from the cell culture sample. Without a 
presence of aptamer, there are only a few translocation events over 10 min. However, after 
1 nM of Pegaptanib aptamer was added into the chamber, we immediately observed the 
nanopore events (figure 17g-h). Translocation of Pegaptanib aptamer (figure 17a-b) and 
Pegaptanib/human expressed VEGF complex (figure 17c-d) were also conducted as a 
comparison with the cell culture media. This experiment demonstrated the nanopore 
sensor’s feasibility of detecting VEGF from cell secretion. Future work includes 
differentiating the events of the aptamer only vs aptamer/VEGF complex in cell culture 







In summary, the fabrication and utilization of a nanopore sensor combining with 
the aptamer to detect the secretion level of an important cancer biomarker, VEGF. First, 
VEGF/aptamer complex reveals orientation selected translocation through the nanopore of 
the negatively charged aptamer followed by positively charged protein, resulting in a well-
defined translocation signature. Nanopore sensor can also differentiate the events of naked 
aptamer and VEGF/aptamer complex. Finally, the aptamers were used to selectively pull 
 
Figure 17. Scatter plots and event amplitude histogram of VEGF/aptamer complex from cell 
culture. (a-b) 1 nM of folded Pegabtanib aptamer translocation (c-d) 1 nM of folded Pegabtanib 
aptamer translocation and 100 nM human-expressed VEGF (e-f) MDA-MB-231 cell culture media 
in nanopore buffer (1:20 dilution ratio) (g-h) diluted cell culture media spiked with a 1 nM of 
folded Pegabtanib aptamer. All experiments were done in a same pore with diameter of 5 nm and 




down the VEGF secreted in cell culture media. Studies are ongoing to determine the VEGF 
secretion in various breast cancer cell lines. Our results highlight the advantages of single 
molecule solid-state nanopore sensors in detection of the proteins based on their functional 
structure, provide further impetus for new designs, and set the stage for implementation of 
such technologies into point-of-care applications. 
 




Figure SI 14. Scatter plots and event amplitude histogram of DNA, folded aptamer, 
unfolded aptamr, and aptamer/VEGF complex. (a-b) 100 pM of 4kbps DNA translocation (c-
d) 1 nM of unfolded V7t1 aptamer (e-f) 1 nM of folded V7t1 aptamer (g-h) 1 nM of folded V7t1 
aptamer with an addition of 100 nM VEGF. All experiments were done in a same pore with 








Figure SI 15 Translocation of VEGF only comparing with DNA only. Scatter plots and event 
amplitude histogram of (a-b) 100 pM of 4kbps DNA translocation (c-d) 1 nM of unfolded V7t1 
aptamer (e-f) 1 nM of folded V7t1 aptamer (g-h) 1 nM of folded V7t1 aptamer with an addition of 
100 nM VEGF. All experiments were done in a same pore with diameter of 6 nm and thickness of 







Figure SI 16. Scatter plots, event amplitude histogram and dwell time histogram of 
V7t1/VEGF complex classified by their signature. (a-b) group A, corresponds to translocation 






Figure SI 17 Relationship of time between each signature level. (green) In event group B1  






Figure SI 18 Current trace (left) and corresponding noise spectrum of media used in cell 
culture experiment. (a) in nanopore buffer containing 1M KCl, 50 mM phosphate buffer saline 
5 mM EDTA pH 7.2. (b) The cis chamber was washed and replaced with 1X PBS.  (c) the cis 
chamber was washed and replaced with 1X CD293 media. (d) the cis chamber was washed and 
replaced with 1X MEM. All experiments were done in a same pore with diameter of 5 nm and 
thickness of 7 nm. The bias was +500 mV at the trans chamber. 
a 1M KCl/1M KCl
b 1X PBS/1M KCl
c 1X CD293/1M KCl
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CHAPTER 4: A SOLID-STATE HARD MICROFLUIDIC NANOPORE 




Integrated diagnostic platforms that combine biosensors within automated 
microfluidic devices are revolutionizing the detection of nucleic acids and proteins. 
Microfluidic systems process and analyze complex liquid samples collected from patients, 
automate and miniaturize laboratory scale sample preparation methods, reduce required 
sample and reagent volumes, and simplify assay complexity by integrating multiple 
components (e.g., sample preparation, acquisition, and quantification) into a single 
design.1–5 There is significant interest in incorporation of sensitive single molecule sensing 
modalities into microfluidic devices that directly detect the biopolymers as well as provide 
additional information on composition, structure, and/or confirmation.  
Single-molecule biosensing techniques employing optical, electrochemical, 
magnetic, microelectromechanical, or ion-sensitive field-effect transistor readouts are used 
to successfully detect a wide range of analytes including nucleic acids 6–10 and peptides.11,12 
Of these technologies, nanopore sensing whereby a biopolymer is threaded through a 2-50 
nm pore, under an applied electrical bias, is an exciting single molecule sensing technique 
at the forefront.13–17 For example, DNA sequencing using a protein nanopore integrated 
into a portable microfluidic device, by Oxford Nanopore Technologies, represents a prime 
example and success.18 Advances in solid-state nanopores are enabling the direct detection 




nanopores offer several advantages over protein nanopores including control over 
nanopore geometry (diameter and thickness), greater mechanical stability, longer operating 
lifetimes, enhanced durability, sites for surface chemical modification, and fabrication 
processes not requiring the use of biologics.19 
A solid-state nanopore is typically a sub-100 nm diameter hole in an insulating thin 
membrane separated by two electrolyte filled chambers. The device is operated by applying 
a voltage potential between the two chambers, which induces a baseline ionic current that 
becomes partially blocked as a charged biopolymer electrophoretically travels through the 
nanopore towards the oppositely charged electrode. The duration, blockage level, and 
frequency of these translocation events provide information on the analyte’s length, charge, 
shape, and concentration. As such, nanopores are used to characterize nucleic acids,20–28 to 
detect proteins,29–32 and to identify epigenetic modifications.33–35 While the nanopore 
sensors are small, the support equipment often needed to purify nucleic acid or protein 
samples, and perform a nanopore experiment (liquid chambers, amplifiers, voltage clamps, 
electrical isolator, etc.) are not. Given the potential of solid-state nanopores as sensitive 
single molecule biosensors, there is significant activity in integrating solid-state nanopores 
with microfluidic devices to expand their utility, to simply the detection process, and to 
accelerate the translation of these biosensors from research laboratories to clinical 
diagnostic settings.   
For example, Jain et al. utilized a microfluidic device made of 
polydimethylsiloxane (PDMS) microchannels integrated with an electron beam sculpturing 




described a PDMS microfluidic device incorporating solid-state nanopore arrays 
fabricated by controlled dielectric breakdown.37 Yanagi et al. reported a microfluidic device 
consisting of an acrylic flow cell integrated with solid-state nanopore arrays for DNA 
translocation detection.38 Recently, Godin and co-workers demonstrated the use of PDMS-
 
Figure 18 Nanopore/microfluidic chip design and assembly. a) A schematic diagram of the 
microfluidic chip assembly. b) Top view design. The channels leading to/from the sample 
preparation chamber and to/from the bottom of the nanopore device are labelled blue, the channels 
leading to/from the top of the nanopore chamber are labelled in red. The blue and red channels are 
both cut into the bottom half of the two-part device. The top half of the device is shown above and 
connects the four through hole channels fed by the red channels on the bottom of the device up 
through the Zeonex plastic to access the top of the nanopore chamber and the green channels. Both 
the red and blue channels flow past fluidically separated embedded electrodes. The bottom half of 
the device has the channels (red/blue) micro-machined on the bottom of the thick Zeonex plastic 
and sealed with a cover slip to form a channel while the top of this half has a feature micro-
machined for the magnet holder (noted by asterisk). The top half is sealed with PDMS glue to the 
bottom half using the 3 micromachined tracks in the top of the bottom half as a guide. c) Zoom in 
cross section of the chip at the nanopore chambers. Noted that the chip bottom is machined from 
both top and bottom side, creating the thinnest layer of ~200 microns (labelled as **). d) A 
photograph of the microfluidic chip in its assembled state. Inset is the transmission electron 





based microvalves to control dielectric breakdown and biological sample access to the 
nanopore.39 Roman et al. described the use of a 3D-printer to fabricate a PDMS based 
microfluidic device incorporating a solid-state nanopore.40 These nanopore-microfluidic 
devices represent successes, however additional opportunities exit for further 
advancements in: 1) liquid handling – e.g., acidic, basic, alcohol solutions; 2) sample 
introduction – e.g., number of ports; 3) sample preparation  - e.g., chemical or biochemical 
reactions performed at room or elevated temperatures; 4) analyte isolation – e.g., 
purification via magnetic beads; 5) analyte detection – e.g., integration of solid-state 
nanopore sensor; 6) adaptability to commercial scale fabrication; and, 7) overall integration 
and automation.  
Herein we describe an integrated stand-alone solid-state nanopore microfluidic chip 
(Figure 18) which offers: 1) material robustness via fabrication from Zeonex thermoplastic; 
2) a reaction chamber for bioassays at room temperature up to 75 °C; 3) an analyte isolation 
chamber compatible with magnetic bead purification methods; 4) a multi-port liquid 
handling system to deliver one to eight solutions; 5) embedded silver chloride electrodes 
 
Figure 19. Fluidic station. a) A schematic diagram of the custom designed test instrument with 






to apply a voltage potential between the two sides of the nanopore; 6) a multilayered design 
enabling independent access to the cis and trans sides of the nanopore chip; and 7) high-
throughput fabrication via thermoplastic prototyping method.41 The microfluidic-nanopore 
setup is easy to use and one can analyze assay volumes as small as 10 µL. Electrical noise 
measurement and DNA translocation experiments demonstrate performance comparable to 
a conventional stand-alone nanopore setup. Finally, single molecule detection of the DNA 
product from a PCR amplification reaction, after magnetic bead DNA separation, is 
accomplished on chip. 
2. Experimental Section 
Microfluidic Chip. The microfluidic chip composed of four Zeonex Cyclo Olefin 
Polymer (COP) layers (Zeon Chemicals, Louisville, KY) with two separable halves. Each 
half was a machined 2 mm thick Zeonex 690R plastic bonded to a 188 μm thick Zeonex 
ZF14 film. Features were micro-machined using a 3-axis Ultra Precision Milling Machine 
(Fraunhofer IPT, Aachen, Germany) using 150 μm by 1 mm end mills and a diamond fly 
cutting wheel. The fluidic channels were 200 μm square in cross section leading to a 40 μL 
nanopore chamber milled to insert/remove nanopore chips. Chambers for the nanopore 
were milled to created cavities to insert AgCl wire electrodes, designed to interface with 
either the top or bottom set of fluidic channels. The chip and cover slips on each half of the 
device were bonded using a solvent assisted thermal bonding method.42 Both the chip and 
cover slip were immersed in decaline:ethanol 35:65 v/v% for 90 seconds and 30 seconds, 
respectively (decahydronaphthalene, mixture of cis+trans, Sigma-Aldrich, St. Louis, MO; 




an ethanol solution for two minutes and dried with compressed air. After the surface 
activation, the chip and cover slip were pressed together in a two-step process for sealing 
the channels in a hydraulic press. The conditions used for pre-bonding were 110 °C and 
101 psi for 10 min, while the final bonding was conducted at 134 °C and 22 psi for 2 min.  
Test Instrument Design. A custom apparatus was designed to facilitate fluidic 
control, thermal regulation, and magnetic control. An aluminum heating block heated by 
an adhesive-backed silicon rubber heating pad (McMaster-Carr, Robbinsville, NJ) 
controlled by a programmable PID temperature controller (McMaster-Carr, Robbinsville, 
NJ) was incorporated under the microfluidic chip holder. Fluidic connections between the 
test instrument and the microfluidic chip were made through an eight-port connector 
(Dolomite, Norwell, MA) to connect the input and output of the top and bottom halves of 
the chip as well as a fifth connection to waste a container from the bottom segment. Nine 
Luer-Lok syringe attachments (IDEX Health & Science, Oak Harbor, WA) connected two 
manual selector valves (IDEX Health & Science, Oak Harbor, WA) and to 0.5 mm ID 
tubing (IDEX Health & Science, Oak Harbor, WA) were incorporated for interchangeable 
fluidic control between each syringe. Electrical connections to the electrodes were made 
through a small terminal block (WAGO, Germantown, WI), and electromagnetic noise was 
minimized by a removable copper faraday cage. A high-pull neodymium magnet 
(McMaster-Carr, Robbinsville, NJ) was manually placed into a machined cavity above the 





Nanopore Chip Fabrication and Electrical Measurement.  The nanopore chips 
were fabricated using an electron beam sculpturing technique 43,44. Briefly, a <1 0 0> 
silicon wafer was coated with SiO2 (500 nm) and low-stress LPCVD silicon nitride film. 
The silicon wafer was etched through with KOH solution, creating a freestanding SiNx 
membrane with a thickness of ~20 nm. NPs were drilled on the SiNx membrane using a 
highly focused transmission electron microscope (JEOL 2010 FEG- TEM, Peabody, MA), 
to sputter the SiNx material away. A 4-6 nm pore was formed within 1 minute of focusing 
the beam. Prior to the experiment, the NP chips were treated with piranha solution (70% 
H2SO4: 30% H2O2) to remove potential organic contamination on the surface and enhance 
the hydrophilicity of the pore’s wall, rinsed with DI water for three times, and kept in water.  
To assembly the NP onto the microfluidic chip, the microfluidic channels were 
primed by flowing isopropanol, ethanol, and water through the channels to wet the 
channels’ walls. The NP was placed onto the NP chamber and sealed using the fast-curing 
polydimethylsiloxane (PDMS) glue (Ecoflex 5, Smooth-On, Macungie, PA). 
Subsequently, the top half of the chip was assembled using PDMS glue.  
Both channels were filled with a nanopore buffer containing 1 M KCl, 50 mM TRIS 
buffer, and 5 mM EDTA at pH 8.0 (all of them were purchased separately from Sigma-
Aldrich, St. Louis, MO). All buffers were filtered using a 0.02-µm syringe filter (Whatman 
Anatop 10 syringe filter, Sigma-Aldrich St. Louis, MO) and degassed in vacuum right 
before each usage. All experiments were performed inside a dark Faraday cage at constant 
temperature (22.0 ± 0.5 °C). Two Ag wires were electroplated in 2 M KCl solution to form 




to the top and bottom set of the fluidic channels and connected to an Axon 200B amplifier 
(Molecular Devices, Sunnyvale, CA) as previously described.45 The electrical current 
across the nanopore was low-pass filtered at 100 kHz Butterworth filter and sampled at 250 
kHz. 
Custom LabVIEW software was used to detect the presence of the events due to 
analyte translocation. The starting point of the event occurred when the current dropped 
0.25 nA below the average open pore current and the event end point was defined when 
the current recovered to the open pore current value. The voltage clamp mode was used for 
all experiments. Event classification was performed off-line using a custom LabVIEW 
code to identify the average fractional current blockage (IB = iblock/iopen) and translocation 
dwell time (tD). 
Model DNA translocations. The DNA translocation experiments were performed 
by flowing a nanopore buffer containing 1 nM of 5 kbps NoLimits DNA (ThermoFisher 
Scientific, Waltham, MA) through the microfluidic chip.  
DNA purification on-a-chip. A polymerase chain reaction (PCR) was performed 
(off chip) to create the 5,099 base pairs product from lambda DNA.  
Polymerase Chain Reaction (PCR) protocol The PCR assay was optimized and 
performed in a 50 µL reaction mixture in a PCR tube containing 1 unit of KOD Hot Start 
DNA Polymerase (Millipore Sigma Burlington, MA), 1.5 mM MgSO4, 0.2 mM of dATP, 
dGTP, dCTP and dTTP, and 1X of PCR buffer for KOD Hot Start Polymerase (supplied 
in proprietary recipe). Additionally, 0.3 µM of each primer (Integrated DNA technologies, 




experiments are 5’- AAATGCAGGGTGAGATTGTGGCGC-3’ and 5’- 
ACCCGGGAGTGATTTCCGTCTTACG-3’ for the forward and reverse strands, 
respectively. Small trace of lambda DNA (New England Biolabs, Ipswich, MA) was spiked 
into the mixture. The PCR assay was optimized in a T100TM Thermal Cycler (Bio-Rad, 
Hercules, CA) at the following temperature profile: (1) 90°C for 30 sec, (2) 60°C annealing 
temperature for 1 min, (3) 40°C or 30 sec, repeat (1) - (3) for 20 cycles. Once the reaction 
was done, the solution is kept at 4°C. Finally, the PCR product was verified by agarose gel 
electrophoresis, strained with EtBr, and imaged on Molecular Imager Gel Doc instrument 
(Bio-Rad, Hercules, CA).  
Subsequently, the DNA product was purified using a silica-coated magnetic bead-
based extraction protocol (magJET DNA Plasmid purification kits, Thermo Fisher 
Scientific, Cambridge, MA). Silica-coated magnetic beads were chosen because they bind 
nucleic acids in a pH sensitive manner enabling the selective capture of DNA from a 
biological sample, and subsequent release of DNA upon changing the pH. Furthermore, 
the magnetic core facilitates DNA isolation and purification using the magnet in the 
microfluidic chip. Lastly, the reactions in this purification procedure are mild, and do not 
deteriorate or adversely affect the nanopore.  
The purification process involves five overall steps: 1) placement of magnetic bead 
nanoparticles inside the bioassay reaction/purification chamber of the microfluidic device; 
2) binding of the DNA product to the magnetic beads; 3) rinsing the sample to remove 
unwanted contaminants; 4) releasing the DNA from the beads; and, 5) transferring the 




nanopore buffer solution containing 1 M KCl, 50 mM phosphate buffer and 5 mM EDTA 
at pH 8.0 was flowed into the nanopore chamber (shown in red in figure 18a) through the 
reaction/purification chamber chamber (shown in blue in figure 18a). Next, the magnetic 
particle suspension solution (2 µL) was mixed with isopropanol (18 µL), and the mixture 
was introduced into the reaction/purification chamber while the magnet was placed on top 
of the chamber. The valves were configured so that the solution flowed directly to the outlet 
bypassing the nanopore chamber. Next, the crude PCR solution (10 µL) was mixed with 
the neutralization solution (40 µL), and transferred to the reaction/purification chamber. 
The injection was stopped once the solution mixture reached the chamber. The magnet was 
removed and the temperature controller was turned on to heat the reaction chamber to 70 
°C for 10 min. After the chamber was cooled down to room temperature, the magnet was 
placed back and 50 µL of the rinsing buffer was flowed through the chamber. Finally, 10 
µL of the TE buffer (10 mM Tris-Cl buffer, 1 mM EDTA, pH 8.0) was incubated with the 
beads at 50 °C for two minutes to elute the nucleotides from the beads. Finally, the outlet 
flow was directed to the nanopore chamber so that the elution buffer containing pure DNA 
product was sent to the nanopore chamber for electrical detection. The purification process 
required approximately 15 minutes. 
 
3. Results and Discussion 
3.1 Device assembly and NP integration. 
An integrated microfluidic device containing a solid-state nanopore sensing module 




are typically 2D designs, the need to access both the top and bottom faces of a nanopore 
required a more complex multi-layer microfluidic design. The integrated nanopore-
microfluidic device is composed of up-to five layers of silicon chip, plastics, and cover-slit 
sheets precisely aligned. The 3D microfluidic design is shown in Figure 18 with both the 
top (red) and bottom (blue) fluidic pathways highlighted. Each channel or pathway passes 
a fluidically isolated electrode at the entrance to either the cis (top) or trans (bottom) side 
of the nanopore biosensor. Each half of the device consists of a 2 mm and 188 μm thick 
Zeonex Cyclo Olefin Polymer (COP) plastic bonded together to form fluidic channels 
based on micro-machined features in the 2 mm thick segment. Zeonex plastic was chosen 
for its optical and mechanical properties, including transparency, low auto-fluorescence, 
high glass transition temperature, solvent resistance, and machinability. It also features low 
moisture absorbance and biocompatibility with DNA and proteins.46  
In addition to two nanopore chambers formed on top and below the nanopore chips 
(shown in red in Figure 18a), the bottom chip contains a sample reaction/purification 
chamber for magnetic bead purification consisting of a 50 μL reaction volume below a 
micro-machined cavity designed to hold a magnet (shown in blue in Figure 18a). This 
chamber has its own outlet waste stream to introduce unprocessed sample and bypass the 
nanopore chamber. Upon completion of the purification protocol, the analyte of interest is 
released from the magnetic beads and flowed through the inlet channel to arrive at the 
nanopore sensing module of the device.  
The NP was installed by sealing a nanopore chip within the bottom half of the 




bottom half of the device using two circular tracks as a guide for PDMS application (Figure 
18). This assembly process yielded fluidically isolated AgCl electrodes within the sensing 
module that are electrically connected only through the nanopore biosensor.  
A custom build test instrument was designed to streamline the fluidic, temperature, 
and electronic control of the microfluidic device (Figure 19). The chip was interfaced to an 
8-port assembly (while one port was used to connect to a waste container, only five ports 
were used to connect to the reaction solutions in the current experiments) with Dolomite 
connectors for easy “plug-and-play” access to the fluidic channels. The five fluidic lines 
were then connected to a manual selector valve with nine Luer-Lok syringe connectors for 
an easy access. Based on the pathways chosen by the selector, any syringe can be used to 
access the device allowing for facile transitions between samples and buffers during an 
experiment. In addition to providing a chamber for magnetic bead capture, this same region 
of the chip was mechanically clamped to a temperature controller using an aluminum heat 
block, controlled by a programmable PID temperature controller. In order to minimize 
electromagnetic noise and to provide an easy interface between the microfluidic electrodes 
and the external electronics that operate the nanopore biosensor, electrical connections to 
the electrodes were made through a small terminal block, and the entire device was 
enclosed within a copper faraday cage.   
3.2 Verification of device’s fluid integrity 
The device integrity was first validated by assembling the device with a silicon chip 
not possessing a nanopore. A blue food dye solution was introduced into the assembled 




No leakage between layers was observed. The AgCl electrodes were then inserted into the 
two chambers, and we measured the electrical signal. No electrical signal was detected in 
this test setup confirming that the microfluidic chip was electrically isolated between the 
two chambers. To address the device integrity under high temperature, the microfluidic 
device was heated to 70 °C for an hour. Again, no dye leakage was observed and the 
 
Figure 20. Electronic characterization of the microfluidic-nanopore device. a) An open 
pore current trace of a 7 nm diameter nanopore (25 nm thickness) in a conventional chamber. 
The open pore current is 6.85 ± 0.18 nA. b) An open pore current trace of the same pore, but 
assembled into the microfluidic chamber. The open pore current is 6.96 ± 0.19 nA. Both traces 
were measured using a 100 KHz bandwidth. c) Comparison of the power spectral density of 
the current in the conventional system and microfluidic system. The electrolyte solution is 1 M 
KCl 50 mM phosphate 5 mM EDTA. +500 mV bias toward trans chamber. The data were 
passed through the low-pass filter at 100 kHz and collected by the Axopatch 200B Amplifier 





electrical signal was isolation between the two chambers. 
3.3 Device’s electrical integrity and noise analysis 
Next, we compared the electrical performance of a nanopore assembled in a 
conventional setup and the microfluidic setup. A nanopore was assembled into a 
conventional in-house setup made of Teflon.47 Ionic current flow through the nanopore was 
measured as a function of incremental voltage ramp (Figure 20a). Linear regression 
analysis was used to obtain the pore’s conductivity of 7.31 ± 0.24 nS (R2 = 0.99); figure 
20a). The diameter of the nanopore was calculated based on the equation;13 
      (1) 
where Gopen is the conductivity during the open pore state, σ is the bulk conductivity, dpore 
is the diameter of the pore and l is the thickness of the membrane. The thickness of the 
membrane was pre-determined experimentally using ellipsometry to be 25 nm. From this 
equation, the pore’s diameter was calculated to be ~5.0 nm, and in agreement with the 
measurement obtained by electron microscopy obtained immediately after pore formation.  
Subsequently, the nanopore was removed from the conventional setup and 
assembled into the microfluidic setup. The open pore current conductivity was determined 
to be 5.95 ± 0.349 nS (R2 = 0.98), corresponding to a calculated pore diameter of ~4.5 nm. 
The slight decrease in open pore diameter is likely a result from disassembling and 
reassembling steps, as it involves drying the chip and a slight reduction in the pore’s 
wettability. In a separated experiment, we directly assembled a new pore into the 






The electrical noise data collected in a conventional in-house nanopore system 
compared to the microfluidic system are shown in Figure 21. A +500 mV voltage was 
applied to the cis chamber, and the open pore current was recorded at full bandwidth. The 
 
Figure 21. I-V curve of 4.5 nm pore (25 nm thickness) inside a) the standard Teflon insert, b) 
the microfluidic device. The standard deviation shows the root-mean-square noise of the 




Figure 22. Representative translocation events of a model 5 kbps NoLimits DNA collected 
with the nanopore in the conventional system (a) or (b) microfluidic system. Both datasets were 





open pore current in a conventional setup had a root-mean-square noise of 185 pA (figure 
21a) measured at 100 KHz. While in the microfluidic system using the same pore, the root-
mean-square noise was 192 pA (figure 21b), and similar to the measurement obtained on 
the conventional nanopore setup.  
Apart from the root-mean-square noise during the continuous readout, the spectral 
noise in the frequency domain is also critical for the nanopore measurement. To maximize 
the temporal resolution of our system, we used the full bandwidth of our amplifier (~100 
kHz) and examined the noise in the system by performing power spectral density 
measurements. The microfluidic system consistently produced a current with low-1/f noise 
level, comparable with the conventional setup shown in figure 21c.  
3.4 Model DNA translocations 
We performed DNA translocation experiments using a 5 kbps long DNA, as a 
model representative DNA sample to evaluate the performance of the chip. First, we 
performed DNA translocation through a nanopore assembled in the conventional setup with 
an applied bias of +500 mV. The current versus time traces showed the characteristic events 
(Figure 22a). A couple hundred of events were collected (N = 231), and analyzed to create 
a scatter plot of the fractional blockage current (IB) and translocation dwell time (tD) (Figure 
23a). The dwell time histogram was fit to an exponential decay function to give the 
characteristic translocation time of 103 ± 18 µs (Figure 23c). The event amplitude showed 
single level translocation clustering at 0.70 ± 0.20 and 0.88 ± 0.08, (Figure 23e) when fitted 
by a bimodal distribution. The expected blocked level of the DNA inside the pore was 
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where dDNA is diameter of DNA (2.3 nm). Thus, the first event amplitude clustering 
at IB ~ 0.88 reflected collision events when the DNA attempted to enter the pore while the 
second population at IB ~ 0.70 corresponded to DNA successfully translocating through the 
pore.24 
Once the experiment was completed, the nanopore was removed from the 
conventional setup insert and assembled into the microfluidic device, and the translocation 
experiment was performed again with the model 5 kbps DNA (Figure 23b). Analysis of the 
event amplitude and dwell time revealed that the translocation average event amplitude 
again contained two peaks at 0.70 ± 0.20 and 0.88 ± 0.08 (Figure 23f; N = 304) for the 
collision and translocation populations, respectively. This result was similar to that 
observed in the previous experiment. The characteristic translocation time was determined 







Figure 23. Analysis of the model 5 kbps DNA translocation events results in translocation 
dwell time (TD) and fractional current amplitude (IB). Each dot in the scatter pot represents the 
individual translocation event. a) The scatter plot of translocation events in regular insert, 
comparing with the translocation events in microfluidic system (b). c) The translocation time 
histogram inside a regular insert. The histogram was fit with exponential decay to yield the 
characteristic translocation time of 103 ± 18 µs (N = 231). d) The translocation dwell time of the 
events in microfluidic chip. Fitting results characteristic dwell time of 111 ± 21 µs (N = 304). The 
event amplitude histogram shows bimodal distribution which peaks are at 0.70 ± 0.20 and 0.88 ± 
0.08 for conventional insert and 0.63 ± 0.20 and 0.86 ± 0.17 for microfluidic insert, respectively. 
The experiment was done in the same pore (4.2 nm diameter, 5 nm thickness). For more 




3.5 Streamline DNA purification on a chip 
To demonstrate the utility of the microfluidic chip to purify a DNA sample from a 
crude PCR reaction prior to nanopore sensing, we performed the following experiment. 
After the PCR reaction was completed, 10 µL of the crude PCR solution was flowed into 
the microfluidic system at point a (Figure 24 chip diagram). The injection was halted once 
the solution reached the reaction/purification chamber. Next the silica-coated magnetic 
beads were injected into the chamber (the magnet was removed so that the DNA sample 
mixed and interacted with the magnetic beads freely in solution). The temperature of the 
chamber was increased to 70 °C for 10 minutes using the heating block, followed by 
cooling down to room temperature for another 10 minutes.  The magnet was then placed 
on top of the chamber to collect the DNA-trapped magnetic beads while the remaining 
solution was washed from the chamber and removed via the outlet (Figure 24b). An 
additional rinsing step was performed with the wash solution. Finally the elution buffer, 
containing 10 mM Tris-EDTA buffer, was added to the reaction/purification chamber and 
the magnet was removed to allow the magnetic beads to disperse into the buffer solution. 
The microfluidic chip was then heated again to 50 °C for 2 minutes to facilitate the 
desorption of DNA from the magnetic beads (Figure 24c). Finally, the elution buffer 
containing DNA was flowed into the nanopore, and the translocation of the DNA through 
the nanopore was measured (Figure 24d). The event analysis revealed the characteristic 
translocation time of 125 ± 18 µs (N = 385) and event amplitudes of 0.51 ± 0.20 and 0.83 
± 0.20. Translocation of the 5 kbps NoLimits DNA in the same buffer condition yields 






In summary, the fabrication and utilization of an integrated microfluidic-nanopore 
biosensor is described. This microfluidic-nanopore system exhibits comparable electrical 
noise to that observed in a conventional setup. DNA translocations are similar whether the 
 
Figure 24. On-chip PCR purification and nanopore sensing. a) diagram of a nanopore-
microfluidic chip. b) A PCR amplicon was generated from lambda DNA template with KOD Hot 
Start Polymerase and the crude PCR solution was injected into the microfluidic chip for 
purification. (i) The DNA product from PCR reacted with the silica-coated magnetic nanoparticles 
inside the reaction chamber. (ii) The magnet is placed on top of the chip to pull down the DNA 
product. (iii) The beads were washed and released using elution buffer. (iv) The DNA product 
was sent to the nanopore for detection. c) Representative electrical current measured during each 
step. d) Representative DNA translocation. e-g) Analysis of DNA events. The experiment was 





solid-state nanopore is in the microfluidic device or the conventional setup.  The 
microfluidic-nanopore biosensor possesses a reaction/purification chamber for performing 
bioassays and purifications at a controlled and defined temperature. Finally, separation of 
an analyte from the surrounding biological milieu is accomplished using magnetic beads. 
Thus, this method and the resulting biosensor are readily applicable to a number DNA and 
protein sensing applications. Studies are ongoing to refine the chip for simultaneous 
electrical and optical detection 23,48 via the nanopore. Our results highlight the advantages 
of combining thermoplastic microfluidic technologies with single molecule solid-state 
nanopore sensors, provide further impetus for new designs, and set the stage for 
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Figure SI 19. Full-length agarose gel electrophoretic image of the PCR result, stained by 
EtBr. Two annealing temperatures, at 60°C and 65°C were chosen for optimization. The 5-kbps 
DNA product presented as intense bands at the correct distance. Other bands of ~1.2 kbps DNA 
by-product were also visualized. We proceeded with 60°C as an annealing temperature for the 

















5.2 Spectrophotometer results of magnetic bead purification assay optimization  
 
Figure SI 20. Four step processes associated with on-chip purification nanopore sensing 
technique. (a) The mixture contained DNA target was incubated with silica-coated magnetic 
nanoparticles at 70°C to facilitate the binding. The particles were washed sequentially using 
proprietary wash solution for 3 times and incubated in Tris-EDTA buffer at 50°C to facilitate the 
release of the DNA from the silica surface. The DNA were sent through the nanopore sensor. (b) 
5-kbps NoLimits DNA were used to optimized the bead assay. The absorption spectra of the bulk 
solution were obtained at each step using Nanodrop 2000 Spectrophotometer (ThermoFisher 
Scientific, Cambridge MA). (c) The DNA solution concentration calculated form the absorption 





































































5.3 Additional experiment of DNA translocation inside a regular insert vs. a 
microfluidic insert 
 
Figure SI 21. Additional experiment of DNA translocation. a) Representative translocation 
event of 5 kbps NoLimits DNA inside the conventional system. b) representative translocation 
events inside the nanopore-microfluidic system. c) The scatter plot of translocation events in 
regular insert, comparing with the translocation events in microfluidic system (d). e) The 
translocation time histogram inside a regular insert. The histogram was fit with exponential decay 
to yield the characteristic translocation time of 219 ± 26 µs (N = 254). f) The translocation time of 
the events in microfluidic chip. Fitting results characteristic dwell time of 202 ± 18 µs (N = 175). 
g-h) The event amplitude histogram shows bimodal distribution which peaks are at 0.83 ± 0.09 and 
0.91 ± 0.06 for conventional insert and 0.82 ± 0.07 and 0.93 ± 0.06 for microfluidic insert, 
respectively. Both datasets were obtained from the same experimental condition using the similar 




5.4 Additional experiment on bead-released assay 
 
Figure SI 22. Additional experiment on On-chip PCR purification and nanopore sensing. A 
PCR amplicon was generated from lambda DNA template with KOD Hot Start Polymerase and the 
crude PCR solution was injected into the microfluidic chip for purification. (a) The DNA product 
from PCR reacted with the silica-coated magnetic nanoparticles inside the reaction chamber. (b) 
The magnet is placed on top of the chip to pull down the DNA product. (c) The beads were washed 
and released using elution buffer. (4) The DNA product was sent to the nanopore for detection. The 
bottom panel presents associated electrical current measured during each step.  
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CHAPTER 5: CONCLUSIONS AND FUTURE PERSPECTIVES 
Monitoring individual proteins in solution while simultaneously obtaining tertiary 
and quaternary structural information is challenging. In this study, translocation of the 
vascular endothelial growth factor (VEGF) protein through a solid-state nanopore (ssNP) 
produces distinct ion-current blockade amplitude levels and durations likely corresponding 
to monomer, dimer, and higher oligomeric states. Upon changing from a non-reducing to 
a reducing condition, translocations from the monomeric state dominate, consistent with 
the expected reduction of the two inter-chain VEGF disulfide bonds. Cleavage by plasmin 
and application of either a positive or a negative NP bias results in protein translocations 
corresponding either to the VEGF receptor recognition domain or to the heparin binding 
domain, accordingly. Interestingly, multilevel analysis of VEGF translocation reveals how 
individual domains affect the translocation pattern. Our study shows that careful 
characterization of ssNP results elucidates real-time structural information about the 
protein, thereby complementing classical techniques for structural analysis of proteins in 
solution with the added advantage of quantitative single-molecule resolution of native 
proteins.  
For use in a clinical setting, solid-state nanopore sensing requires sample 
preparation and purification, fluid handling, a heating element, electrical noise insulators, 
and an electrical readout detector, all of which hamper its translation to a point-of-care 
diagnostic device. A stand-alone microfluidic-based nanopore device is described that 
combines a bioassay reaction/purification chamber with a solid-state nanopore sensor. The 




formed via micro-machining and heat bonding, enabling the use of both a heat regulator 
and a magnetic controller. Fluid control through the microfluidic channels and chambers 
is controlled via fluid port selector valves and allows up-to eight different solutions. 
Electrical noise measurements and DNA translocation experiments demonstrate the 
integrity of the device, with performance comparable to a conventional stand-alone 
nanopore setup. However, the microfluidic-nanopore setup is superior in terms of ease of 
use. To showcase the utility of the device, single molecule detection of a DNA PCR 
product, after magnetic bead DNA separation, is accomplished on chip.  
After completion of my work, I anticipated that the future direction of this single-
molecule protein-sensing using nanopore sensor will head towards; 
1. Robust signal processing and understanding the protein translocation signal 
Future NP analysis will include more sophisticated signal processing algorithm 
such as Wavelet Transform (similar to EKG signal), competent composite method (similar 
to data compression technique). Classifying the signals can be done by machine learning 
algorithms via supervised learning (such as support vector machine or neural network) or 
unsupervised learning (such as kmeans). Computational simulation both in atomic and 
higher level could shed light on how a protein molecule translocate or interact with the 
pore, however, such technique required very high computational power to account for 
translation, rotation, as well as structural unfolding of the protein.  
2. Device development 
Although nanopore sensors are used in a number of laboratories and commercial 




1) higher temporal bandwidth, while minimizing noise, in order to resolve nanopore 
event with shorter dwell time and capture more proteins of low copy number present in 
solution; 
2) innovative fabrication technique to precisely create ultra-thin and ultra-small 
sensing region, down to Angstroms, enable identification of individual amino acids in a 
protein; 
3) expansion of emerging detection modality such as optical readout or transverse 
current readout to obtain additional information from the protein translocation event; 
4) improved methods for high-throughput nanopore fabrication. Alternative NP 
fabrication techniques such as dielectric breakdown and laser-based drilling might be an 
answer to the issue of nanopore reproducibility and mass-production; 
5) auxiliary devices to connect with the nanopore or multiuse integrated nanopore 
devices (e.g., microfluidic nanopore device) to enable the sensing of biological and clinical 
samples wherein the sample is isolated, purified, and delivered to the nanopore for sensing. 
3. Future applications 
The availability of low-cost, single molecule protein sensing technology based on 
nanopores will undoubtedly advance basic research in molecular biology and medicine. 
Moreover, and nanopore technologies for protein sensing and characterization will be 
quickly adopted for commercial use in broad range of fields, including biomedicine 
(molecular diagnostics and drug development), biotechnology (food industries and water 
quality control), forensics and much more. One of the specific applications for nanopore 




ensure a specific and unique signal from the translocation event for a given protein, as 
demonstrated in the section 3.5. Multiple proteins could simultaneously be detected using 
a single assay (with different designed tag and signal processing). Another specific 
example involves quantification of enzymatic activities. Given the ability to study protein 
binding and enzyme reaction kinetics, the nanopore provides a means to study protein 
reactivity at the single molecule level as it is a critical information for drug discovery, 
replacing the use of laborious bulk measurements such as 2D gel electrophoresis or ELISA. 
With regards to clinical applications, nanopore sensors require minimal sample and thus 
screening or identifying a specific protein in a patient’s blood or urine sample could be 
done non-invasively. Alternatively, nanopore sensor may be coupled with controlled 
microfluidic channels device to create a single-molecule sorting device. Nanopore-based 
peptide sequencing is a long way, giving a challenge in producing a fine readout that a 
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